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Stephen R. Wisniewski, PhD 
Chronic pancreatitis (CP) is a major burden of gastrointestinal disease in the United States 
accounts for significant healthcare costs to the society. Abdominal pain is the most common 
symptom in CP patients and the development of CP is challenging medical practice. It has been 
proposed that a combination of genetic, environmental, and metabolic risk factors contribute to 
the pain patterns in CP patients and development of CP. This research aimed to introduce a new 
data analytic strategy Random Forests (RF) to support big data analysis in studying CP and 
epidemiological researches. 
RF has been becoming a popular non-parametric algorithm in computational method and 
used in many scientific areas in the context of big data era. RF is an ensemble of individual 
decision trees to help explore data structure and hidden information in high dimensional data. RF 
could deal with correlated predictor variables and integrates complex interaction effects during 
modeling process to evaluate the entire effects of all predictor variables on outcome variable and 
produce estimates of importance scores for all predictor variables. 
In this work, a framework of combining RF analyses with traditional statistical analyses 
was developed to investigate important risk factors associated with different pain patterns in 
patients with CP and disease progression from recurrent acute pancreatitis (RAP) to CP. The 
A COMPUTATIONAL METHOD FOR THE ANALYSIS OF PAIN PATTERNS AND 
PROGRESSION OF PANCREATITIS WITH A LARGE NUMBER OF PREDICTOR 
VARIABLES 
Ye Tian, PhD 
University of Pittsburgh, 2014
ABSTRACT 
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public health significance of this novel analytic method is that it successfully examined a large 
amount of predictor variables in a multivariable way and would help researchers to better 
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1.0  INTRODUCTION 
1.1 PANCREAS 
The pancreas is an organ about six inches long and is located deep in the abdomen, behind the 
stomach. It is made up of glandular tissue and a system of ducts. The main duct is the pancreatic 
duct which runs the length of the pancreas and has many small side branches. It drains the 
pancreatic fluid from the gland and carries it to the duodenum, the first part of the small 
intestine. The pancreatic duct is merged with the bile duct in the head of the pancreas to form a 
widening of the duct just before it empties into the duodenum.[1]  
The pancreas is both an endocrine and exocrine gland that has a critical role in energy 
balance and digestion.[2] The endocrine cells (islets of Langerhans) of the pancreas produce and 
secrete hormones (e.g. insulin and glucagon) into the bloodstream to maintain the proper level of 
sugar in the blood used for energy. The exocrine cells (acinar cells) of the pancreas produce and 
transport inactive digestive enzymes that go through pancreatic duct. These cells are secreted in 
the small intestine where they are activated to assist in the digestion of food. However, when 
pancreatic enzymes (especially trypsin) are activated in the pancreas instead of the small 
intestine, it will cause pancreatic injury, inflammation of the pancreas, and immune responses 
that are recognized as pancreatitis.[2] 
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1.2 PANCREATITIS 
Pancreatitis is a major contributor to the burden of gastrointestinal disease in the United 
States.[3-5] In 2004, there were 475,000 hospital visits and 277,000 hospitalizations due to 
pancreatitis as the primary diagnosis in the United States. The number of hospitalization for 
pancreatitis increased 62% from 1988 to 2004, with the $3.7 billion total estimated health care 
cost in 2004.[4, 5] Defined as an inflammation of the pancreas, it can be acute or chronic, 
requiring medical treatment ranging from minor outpatient management to intensive care for 
organ failures.[6, 7] The most common symptom in both acute and chronic pancreatitis is the 
upper abdominal pain radiating to the back with other symptoms, such as nausea, vomiting, and 
abdominal distension, depending on severity and etiology of the disease.[8, 9] 
1.2.1 Acute Pancreatitis 
Acute pancreatitis (AP) is a sudden inflammation of the pancreas and commonly result in 
hospital admissions.[8] In the United States, the annual incidence of AP is 42/100,000 
population.[10] In 2009, AP accounts for about 274,119 hospitalizations in the United States, 
which is the most common single gastrointestinal disease of hospital admissions.[11] The 
mortality rate is less than 5% for those younger than 40 years old but increased to 28% or higher 
in those older than 60 years old.[12] Most AP is associated with minor organ dysfunction, and 
commonly resolves within seven days with supportive medical treatment including pain 
medications, fasting, and intravenous nutritional support. [13] Alcohol abuse and gallstones are 
the most common etiological factors for AP, accounting for over 80% of cases in Western 
countries.[8] AP could be confirmed by a battery of  diagnostic tools such as physical 
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examinations, laboratory tests, and imaging studies, to determine severity and presence of 
bleeding in or around the pancreas.[8, 13] While most of AP patients are often successfully 
relieved by supportive medical treatment, severe cases of AP may require admission to the 
intensive care unit, endoscopic therapy, or surgery to deal with complications of the disease 
process because of the development of a systemic inflammatory response (SIRS) and multiple 
organ failure (MOF).[13-15], which result in majority of death in patients with AP.[16] 
1.2.2 Recurrent Acute Pancreatitis 
For majority of patients who have a first episode of AP, physicians can usually determine and 
treat the underlying cause of disease so that AP never returns. However, any established risk 
factor that is associated with a patient having the first episode of AP has the potential to initiate 
the subsequent attacks within a few years.[17, 18] Recurrent acute pancreatitis (RAP) is defined 
as patients having two or more attacks of AP without morphological changes to the pancreas 
detected by imaging studies including CT scan, endoscopic retrograde cholangiopancreatography 
(ERCP), magnetic resonance cholangiopancreatography (MRCP), or endoscopic ultrasound 
(EUS), etc.[19] The median time of the first readmission for AP is 7.2 month and the proportion 
of patients developing RAP after the first event of AP ranges from 4.2% to 14.4% and the 
mortality rate of RAP is lower than AP (<1% -3.2%).[3, 12] Even though the mortality rate of 
RAP is lower than the first episode of AP, RAP may be associated with impairment in quality of 
life.[17] 
Similar to AP, 70% to 80% of cases of RAP are associated with either alcohol abuse or 
gallstone. Other risk factors include hypertriglyceridemia, smoking, pain medications for first 
attack of AP, etc.[17, 18] Because of the most causes of AP can lead to recurrent attacks if the 
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underlying risk factor remains uncorrected, patients having recurrent attacks of AP need a more 
extensive examination to determine the underlying cause.[2] Patients with RAP should be treated 
with the same supportive treatment such as pain medications, fasting, and intravenous nutritional 
support as those with AP. The need for any other specific treatment, such as endoscopic therapy 
or surgery depends on the underlying causes (e.g. gallstone pancreatitis) for prevention of more 
attacks.[17] 
1.2.3 Chronic Pancreatitis 
Chronic pancreatitis (CP) is defined by pathological evidence of progressive pancreatic damage 
with inflammation, fibrosis, anatomic features (e.g. calcification) and loss of function.[2] There 
are few epidemiological data in the world describing the incidence, hospitalization rate, and 
prevalence of CP probably due to the non-consensus of diagnosis criteria of CP.[20] Yadav et al 
reviewed few data and showed that the annual incidence of CP ranges from 5 to 12/ 100,000 
population, and the prevalence of CP is about 50/100,000 popualtion.[11] Although the 
incidence of CP is significantly lower than that of AP, CP is significantly associated with 
impairment of quality of life since patients diagnosed with CP usually have repeated intermittent 
or continuous abdominal pain, maldigestion, steatorrhea, hospitalization, or diabetes 
mellitus.[21] In addition, patients with CP has been shown to have an increased risk of 
pancreatic cancer, which typically has an extremely poor prognosis.[21-23] 
The etiology and mechanisms of CP is still under investigation and only partially 
known.[2] In 20th century, alcohol abuse has long been characterized as the primary cause of 
CP. From last decade, however, recent multicenter studies showed that only about 34% to 44% 
of CP cases having alcohol abuse as the primary single cause considered by physicians.[24, 25] 
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Other important risk factors include hyperlipidemia/hypertriglyceridemia, pancreas divisum, 
sphincter of oddi, pancreatic duct obstruction, early or late idiopathic etiologies, and other toxic 
causes, such as smoking, medication (e.g. valproate, phenacitin, thiazide, oestrogen, and 
azathioprine) etc.[22] In addition, a number of genetic susceptibility factors have been identified 
with CP.[2, 21, 22, 26-30] Recent advances in genetics, such as genome-wide association studies 
(GWAS) and next generation sequencing (NGS) technology provide new possibilities to 
accurately identify risk factors leading to CP.[26, 28, 29, 31] The Midwest Multicenter 
Pancreatic Study Group drafted a “TIGAR-O” classification system to categorize major 
predisposing risk factors to CP including toxic-metabolic, idiopathic, genetic, autoimmune, 
recurrent and severe AP associated, and obstructive risk factors (Figure 1).[2, 21] Through recent 
studies, an important conceptual change in understanding the development of CP is that there is 
not a single etiology for CP, but rather it is a complex, multi-factorial disease with different 
pathways and interactions. Moreover, it is possible that other yet-to-be-identified genetic and 
environmental risk factors may play in the complex mechanisms.[2, 22, 24, 26, 28-30] 
There are no definite criteria and limited consensuses on the diagnosis of CP.[21] As in 
other diseases, tissue diagnosis should be the gold standard to diagnose CP to identify chronic 
inflammation and irregularly placed fibrosis in the pancreas. However, using pancreatic biopsy 
or resected specimen of pancreas from patients is impractical because of the likelihood of 
triggering AP or other complications.[2, 21, 22] Currently, a combination of clinical features 
including imaging studies (e.g. CT, MRI, MRCP, ERCP, EUS) and functional tests (e.g. 
exocrine pancreatic function test, liver function test) is widely used for diagnosis of CP. The 
selection of the appropriate diagnostic tests depends on resources and individual circumstances. 
For example, use a single imaging study to diagnose long-standing severe CP with extensive 
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calcifications and ductal dilation in the pancreas is simple whereas the detection of early CP with 
minimal morphological changes by any single imaging study or function test is sometimes 
difficult.[21-23] 
The goals of treatment for CP are to relieve acute or chronic pain, slow down the disease 
process to prevent future painful attacks, correct metabolic consequences such as diabetes or 
malnutrition, use endoscopic therapy or surgery to manage complications such as bile duct 
stricture, pseudocyst, portal hypertension, etc.[22] 
1.3 PAIN IN CHRONIC PANCREATITIS 
Abdominal pain in CP is the most common symptom and the largest clinical challenge for both 
the patients and clinicians. In a recent large multicenter cohort study with 540 CP patients from 
the North American Pancreatitis Study-2 (NAPS2), pain is present in 77% of patients with 
different patient self-identified pain patterns.[32] Some other studies showed that the prevalence 
of pain is up to 90%  and the pain is the primary cause of hospital admissions in CP patients.[5] 
Adversely effects, poor quality of life and increased medical costs are associated with managing 
pain in CP patients.[5] The estimated annual cost to deal with pain in CP patients in the United 
States is over $638 million.[4, 32] 
1.3.1 Mechanisms of Pain 
The mechanisms of pain in CP patients is still under investigation and is very complex. Many 
theories have been proposed over the years and the current consensus is that the pain is multi-
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factorial and heterogeneous among CP patients. [5, 9, 32-36] The multi-factorial causes of pain 
in CP may also explain why the patterns of pain are highly variable and the poor performance in 
current pain management in CP patients.[33] Therefore, understanding the mechanisms of pain 
in CP and risk factors that trigger different types of pain in patients are very important in 
studying pain in chronic pancreatitis. 
There are a variety of hypotheses for the cuase of pain in patients with CP. Originally, 
pain was hypothesized to be related to pancreatic duct hypertension, pancreatic tissue pressure 
and/or neural alterations focused on inflammation and morphologic abnormalities.[5, 9, 33, 35, 
36] Recent researches indicate genetics may play an important role in different phenotypes of 
pain, tolerance, and pain therapy effects. The indication may help physicians to understand the 
question of CP patients who have similar amounts of pancreatic injury but have variant 
expression of pain. However, the evidence of important candidate gene in CP pain is still 
insufficient.[9] 
1.3.2 Pain Patterns 
The characteristics of abdominal pain in CP patients is highly variable among patients. 
Commonly, based on temporality and severity, the pain may be demonstrated as mild or severe, 
intermittent or continuous. The data from NAPS2 study showed that in patients with CP, 
constant pain produces higher rates of disability, hospitalization, and negative impact on quality 
of life compared with intermittent pain, even if the intermittent pain is much more severe in 
intensity.[32] On the other hand, the pain patterns in CP patients may be altered, stabilized, 
worsened, lightened, or disappeared over time, but the progression of pain is not able to predict 
in an individual patient and a specific treatment for pain may be effective, inadequate, or 
 7 
unpredictable.[32, 34] Therefore, these complexities of pain patterns in CP patients may be due 
multiple etiologies.[32, 33, 36] 
1.3.3 Pain Management 
Because the cause of abdominal pain in CP is multi-factorial, and the underlying mechanisms are 
still not completely known, no effective medical therapy or intervention provides reliable relief 
of pain in all patients. Neuropathic pain medications are the most used to conservatively control 
pain in CP patients. The drugs include paracetamol, dextropropoxyphene, prednisolone, non-
steroidal anti-inflammatory drugs, tricyclic antidepressants or narcotic analgesics, etc.[35, 37] 
However, a problem with the use of analgesic drugs is that patients often become addicted on 
heavy dosage.[9, 33, 35] 
Pancreatic enzyme may be used as an alternative for pain control in CP patients because 
of its ability to diminish stimulation of the exocrine pancreas, thereby reduce pain. However, the 
results from a meta-analysis showed that there was no significant benefit of pancreatic enzyme 
therapy to relieve pain associated with CP.[38] In addition, octreotide and antioxidant therapy 
have also been evaluated from a few of studies but showed no statistically significant benefits for 
pain control in patients with CP.[9] Therefore, further studies are needed before they can become 
widely used. 
Endoscopic therapy is focused on relieving pain in CP patients due to pancreatic duct 
obstruction from strictures or gallstones and surgery are primarily used in those with a dilated 
pancreatic duct. Surgical therapy, such as ductal drainage or resection is used in CP patients who 
require long time use of pain medications, or are unable to maintain normal daily life and quality 
of life because of chronic or recurrent pain.[9] 
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1.4 GENETICS IN PANCREATITIS 
In the last two decades, genetics is becoming an important area in exploring pancreatic diseases. 
A number of pancreatic-targeting genetic factors have been identified in influencing trypsinogen 
activation and are associated with changes in susceptibility to pancreatic diseases, including 
cationic trypsinogen (PRSS1), anionic trypsinogen (PRSS2), serine protease inhibitor Kazal 1 
(SPINK1), cystic fibrosis transmembrane conductance regulator (CFTR), chymotrypsinogen C 
(CTRC), calcium-sensing receptor (CASR), and claudin 2 (CLDN2).[2, 21, 26, 28, 31, 39, 40] 
These genetic factors are associated with premature activation of trypsinogen to trypsin or the 
failure to eliminate active trypsin within the pancreas that cause pancreatitis.[28] In addition, it is 
now widely recognized that pancreatitis is a group of complex inflammatory syndromes that 
appear to involve different combinations of genetic, environmental, and metabolic factors, etc.[2, 
26, 39, 41] 
A breakthrough in genetics to understand RAP and CP was discovered in 1996. 
Mutations in the gene that encodes PRSS1 was linked to hereditary pancreatitis, a syndrome 
characterized by RAP and later CP.[42] Later, mutations in gene that encode SPINK1 and CFTR 
were identified that related to pancreatitis. Mutations in CTRC and CASR were also reported 
with small risk with pancreatitis. These genes have different roles in the disease pathways and 
the different mutations within each gene have different functional effects to determine each 
gene’s relative contribution to the various forms of CP.[26, 28, 30, 31] However, all these 
susceptible genetic factors have been found using simple hypothesis-driven candidate-gene 
approaches on the trypsin-activity model which may be incomplete compared to most recent 
genomewide association study (GWAS), which provides the opportunity to perform an complete 
search for genetic risk factors and discover new genetic variants in thousands of genes,[26] The 
 9 
recent NAPS2 project was successfully organized and aimed to perform GWAS to provide new 
insights into the etiology and pathogenesis of RAP and CP.[24] A recent breakthrough from 
NAPS2 was reported that the mutations in PRSS1-PRSS1 and CLDN2 was related to pancreatitis 
which could help to understand the complex genetic variants on effects of RAP and CP.[40] 
1.5 ANALYSIS OF GENETIC DATA 
1.5.1 Genetic Epidemiology 
Genetic epidemiology is an interdisciplinary field to explore both genetic and environmental 
factors and their interactions in determining the distribution of traits and diseases in human 
populations. Previous researches have utilized a simple gene environment model incorporating a 
particular gene variant and an environmental exposure as the potential cause of a chronic disease 
in a regression model to identify association with a gene and disease. In these models, the gene 
environment interaction is defined as their co-participation in mechanism of disease 
development. 
Many chronic diseases are increasingly considered as complex, multi-factorial diseases, 
meaning they are likely associated with the interactive effects of multiple genetic factors in 
combination with numerous environmental factors. Although various chronic diseases, such as 
cardiovascular disease, diabetes and cancers, etc., have been identified that they are substantially 
clustered in families indicating important effect by genetic factors, they do not have a definite 
pattern of inheritance in a family. Thus, it is difficult to predict a person’s risk of developing 
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these diseases simply based on genetic aspects. These complex diseases are difficult to treat 
because some underlying risk factors that cause these diseases have not yet been identified. 
Currently, the field of human genetics research has advanced to include techniques to 
generate high-throughput data.[43] GWAS approaches, which are used to help discover 
thousands of each single-nucleotide polymorphisms (SNP) within genes that are  associated with 
hundreds of common, complex human traits, have been proven to be successful in the 
identification of association between new genetic risk factors and the risk of a wide range of 
complex diseases.[44-46] The most common approach of GWAS is the case-control study which 
compares two large groups of individuals, one case group affected by a disease and one healthy 
control group. All individuals in each group are genotyped for the majority of commonly known 
SNPs. The exact number of SNPs depends on the genotyping technology, but are typically one 
million or more. 
1.5.2 Challenges in Analyzing Genetic Data with Large Number of Variables 
Most GWAS focus on the detection of main effects by using an allele or genotype based test 
separately. However, because genetic factors in combination with environmental factors or other 
genetic factors are expected to contribute to susceptibility to disease, multiple SNPs and 
interaction effects should be analyzed simultaneously.[46, 47] As a result, there are several 
challenges in studying the comprehensive effects of multiple genetic and environmental 
variables. First, in typical GWAS, investigation performed in several thousand subjects with 
genotypes of millions of SNPs, leading to high dimensional data (large p, small n problem, many 
more predictor variables (e.g. SNPs) than study subjects).[43, 48, 49] Second, the large volume 
of risk factors leads to exponentially increase in the number of interactions with different levels 
 11 
that requiring assessment of multiple complex comparisons.[46, 50-53] Third, there is a large 
number of correlated predictor variables (SNPs) genotyped in GWAS needs to be taken into 
account.[50, 54] 
Because of these challenges, standard regression models (e.g. linear regression models, 
Cox proportional hazard regression models, and mixed effects regression models) that have been 
commonly used in assessing the association between the development of a disease and risk 
factors are not sufficient. For example, because of the large number of variables, the variable 
selection and interaction effects for fitting a model is hard to determine. In addition, model 
interpretation can be problematic in the presence of higher-order interactions among hundreds or 
thousands of influential predictor variables. 
1.5.3 Classification and Regression Tree used in Analyzing Large Number of Variables 
Decision tree methods, also called recursive partitioning methods, are a group of computational 
analysis of machine learning algorithms using non-parametric tree structure techniques to handle 
high dimensional data with complex interactions. These methods provide a useful alternative to 
parametric regression methods without the need to specify hypothesis and a particular model.[44, 
49] 
The most common decision tree algorithm is the classification and regression tree 
(CART) introduced by Breiman in 1984,[55] while other methods, such as ID 3 and C4.5 both 
developed by Quinlan in 1986 and 1992 are also used.[56, 57] Decision trees are broadly 
classified into classification trees that used for categorical outcomes and regression trees that 
used for continuous outcomes. Decision tree methods are attractive in genetic epidemiology 
because they allow non-parametric analyses of large numbers of genetic variables in small sets of 
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data (large p, small n problem) and can help to identify interaction effects even though genetic 
variable only have small marginal effects on the health status.[44, 49] 
In the computational learning theory, a training dataset is a set of data consisting one or 
more predictor variables and outcome variable to construct a model for discovering potentially 
predictive relationships and/or learning complex structure in the data. A model learned by 
training datatset is based on empirical relationships tend to overfit the data, meaning that they 
can identify relationships in the training dataset but do not guarantee the future use in general.  A 
testing dataset is a set of data that is independent of the training data but follows the same 
probability distribution as the training data. Using the testing dataset could evaluate the 
overfitting in a model trained by the training dataset. 
Using the CART algorithm, the whole sample is divided into two datasets, a training 
dataset and a testing dataset. Using the training dataset, a decision tree begins to build by first 
splitting a root node containing all sample to one of two child nodes, one left and one right as 
illustrated in Figure 2.[58]  This split process is based on a selected splitting rule, such as 
decrease of Gini Impurity for categorical outcome or minimizing residual sum of squares for 
continuous outcome, by testing every predictor variables and find the best one to split the dataset 
into two subsets of the data that are the most different with respect to the outcome of interest. To 
build a complete tree, this process is recursively repeated to split the child nodes until some 
specified stopping criterion (e.g., minimum number of observations in a node for split) is met, or 
to child nodes are completely homogeneous with respect to the outcome of interest so that there 
is no further possible split. After that, a tree is usually “pruned” back by sequentially removing 
the weakest split in the tree to prevent overfitting, because building a large and complex tree that 
closely fits the training dataset tends to have poor fit on a new dataset. This procedure is called 
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“pruning” and helps us to find the optimal tree by evaluating model fit in testing dataset and 
improve its generalizability. After the recursive partition is completed, a predictive value of the 
outcome variable is calculated by weighting the class frequencies in terminal nodes relative to 
the class frequencies in the root node (for classification trees) or the mean of the outcomes (for 
regression trees) from the terminal node. Then the predicted outcome of each observation in 
testing dataset is estimated by sending the predictor values down the tree and taking the 
predictive value from the terminal node into which the observation falls. This process is applied 
for all subjects in testing dataset and then could provide the prediction error by this tree: 
misclassification error for classification trees or mean squared error for regression trees.[55, 59, 
60] 
CART algorithm has several advantages. It is not based on a particular model and easy to 
interpret. The computation runs fast and could incorporate different types of variables 
simultaneously. However, decision trees tend to have a high instability in node split due to small 
changes in data. Even though it has ways to optimize tree for generalizability, it cannot guarantee 
avoiding overfitting and thus do not always have good performance on future dataset. [49, 52] 
One approach to overcome these limitations from a single decision tree is to use an 
ensemble of individual trees. In 2001, Breiman extended his CART algorithm to forest based 
approaches, named as Random Forests (RF),[61] which have become a popular non-parametric 
algorithm in computational method and used in many scientific areas. A RF consists of hundreds 
or thousands of trees which built from a random sub-sample of the original dataset. The 
predicted outcome for each observation is estimated by selecting the most frequently predicted 
category (for classification) or average of predictive value tree (for regression) from each 
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individual tree. Based on some previously published studies, researchers found results from RF 
showed better performance compared to single CART.[52, 59, 61] 
1.6 AIMS 
The aims of this dissertation include: 1) Introduce the principles of RF, review the applications, 
recent development of RF, describe its advantages and limitations, discuss and provide 
epidemiological examples. 2) Use RF to identify and rank important risk factors associated 
different temporal pain patterns in patients who have chronic pancreatitis. 3) Apply RF to 
identify risk factors associated with the risk of having disease progression from recurrent acute 




Figure 1. Risk factors of CP: TIGAR-O classification system 
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 Figure 2. Basic Structure of CART 
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2.0  RANDOM FORESTS FOR EPIDEMIOLOGY IN THE ERA OF BIG DATA 
2.1 ABSTRACT 
The Random Forests (RF) algorithm has become a very useful computational analytic method in 
a variety of research areas for both classification and regression problems. RF is an ensemble 
decision trees featuring by a two-way randomness through random bootstrap sampling and 
random variable selection in tree-building process. RF is a powerful analytic framework to 
analyze large-scale dataset, e.g. variable selection, variable importance estimation, and outcome 
prediction, etc. It has been applied in a number of epidemiological researches especially in 
genetic epidemiology due to its capability to explore data structure and hidden information in 
high dimensional data. This paper is aimed to review RF methodology, provide examples of 
applications to demonstrate how RF works for epidemiological studies in the context of future 
researches, and discuss its advantages and limitations. 
2.2 BACKGROUND 
In epidemiology, researchers seek to understand the association between risk factors and health 
outcomes, assess the importance of risk factors, find the pattern of disease or health status in 
population, and sometimes build models to predict or classify different outcomes of interest (e.g. 
 18 
prognosis, death, treatment effect, etc.). There are a variety of types of studies could be used in 
epidemiological researches depending on study questions that helps to achieve research 
objectives such as cohort studies, case-control studies, and cross-sectional studies, etc. In these 
studies, descriptive measures of frequency, some relative measures as well as absolute measures 
could be used to quantify the association between specific risk factor and health outcome. When 
investigating several candidate risk factors, estimating interaction effects and/or adjusting 
confounding factors, regression modeling is the most common method for the estimation.[62] 
Traditionally, statistical methods including linear regression for continuous outcome, logistic 
regression for binary outcome, Cox proportional hazard regression for survival models, and 
mixed effects regression or generalized estimating equations for repeated outcomes design 
(longitudinal study), have been well developed and are frequently used for data analysis in 
epidemiological studies. 
Advances in technology and computing, accelerated information accrual and exchange 
have led to the “big data era” and is contributing in the development of  epidemiological 
research, such as genetic and clinical epidemiology, etc.[63] Today, data from epidemiological 
studies are much more complex and high dimensional with large number of predictor variable 
that sometimes result in violation of assumptions for traditional statistical models, such as 
distribution of parameters, correlation among predictors variables, and many missing values. The 
large number of predictor variables lead to more complex modeling including complex 
interactions among predictor variables that are difficult to evaluate and interpret from traditional 
statistical analysis. 
Technological advances in genetic epidemiology, such as genomewide association 
studies (GWAS), DNA resequencing, or DNA microarray are among the most revolutionary 
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developed in last two decades that challenging data analysis because they simultaneously analyze 
large amount of genetic markers.[43, 44, 46, 49, 52] As a result, researchers are facing 
significant challenges from these large-scale data in advanced genetic studies, where thousands 
of genes are considered as potential risk factors of a disease, makes traditional statistical methods 
no longer feasible. The highly correlated structure of genetic variables violates the assumption 
required by traditional models. In addition, many undetected mechanisms that involve gene–gene 
interactions and gene-environmental interactions are difficult to pre-specify in traditional models 
especially for higher order interactions. Only a small set of genetic markers are expected to be 
associated with a particular disease while performing variable selection for high dimensional, 
correlated, and interactive genetic variables are challenging for traditional statistical methods. 
2.2.1 Classification and Regression Trees 
Decision tree methods, also called recursive partitioning, are a group of machine learning 
algorithm and have become popular non-parametric analytic approaches for multivariable 
analysis. Recursive partitioning helps to identify important risk factors and their interactions in 
influencing disease and other health outcome in epidemiological areas, particularly widely used 
in genetic studies.[49, 59] 
One of the most popular algorithm of recursive partitioning is Classification and 
Regression Trees (CART) introduced by Leo Breiman et al in 1984.[55] CART are commonly 
used as a predictive model to predict health outcomes, to identify important predictor variables 
associated with the outcome, and/or to visualize the way of predictor variables interact with each 
other, etc. The outcome variable could be either categorical or continuous, such as disease and no 
disease, severity of disease, dead and alive, etc.[58, 64, 65] 
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2.2.2 CART Advantages and Disadvantages 
CART analysis could be used in a wide range of epidemiological studies because it is non-
parametric computational method without statistical assumptions compared to traditional 
statistical models. CART does not require pre-specified variable selections and can incorporate 
many nuisance predictor variables. It can detect complex interactions among predictor variables 
and has specialized methodology to work with missing values and outliers. However, the largest 
disadvantage of individual decision trees is that they are unstable and overfit to the data. A minor 
change in the dataset, such as removing a small set of observations may result in dramatic 
change in decision tree structure, that is, increase or decrease of tree complexity, changes in 
splitting variables and cutting values in a split, and impair the tree performance.[49, 59, 66] 
To overcome the limitations in a single decision tree, an ensemble of single trees, or use 
of forest, could improve the model performance and stability while maintaining advantages of 
individual trees.[59, 61] 
2.3 RANDOM FOREST 
The Random Forests (RF) algorithm is tree-based ensembles machine learning method for 
classification or regression by constructing a great quantity of CART-like decision trees 
featuring by a two-way randomness through random sub-sampling and random variable selection 
in tree-building process.[59, 61] RF was introduced by Leo Breiman in 2001 and is a popular 
non parametric analysis method in areas such as genetic[48, 51, 53, 67-70], biological[71, 72], 
clinical[73, 74], psychological researches[75]. RF is an extension of Breiman’s previous CART 
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algorithm and offers high prediction accuracy and variable importance estimation.[55, 61] It 
could handle high dimensional data with highly correlated predictor variables to identify key 
subsets of variables related to the outcome and integrate complex interaction effects. In this 
paper, we will review the RF methodology and discuss how RF works for epidemiological 
studies. We will review some examples of applications using RF in epidemiological studies and 
its advantages and limitations. 
2.3.1 Random Forests Methodology 
To build a forest of trees, the RF algorithm has a number of steps: First, for each individual tree, 
a different training dataset is created by randomly select two-third of total subjects from the 
original sample resulting in a particular training dataset to build each tree. This process is called 
bootstrapping and these training datasets are called bootstrap samples. After each bootstrapping, 
the remaining subjects from the original sample are called “out-of-bag” (OOB) samples for each 
individual tree that contains one-third of total subjects from the original sample. Each OOB 
sample is used as a testing dataset for that tree and also help to estimate variable importance. 
Using bootstrap sample, each tree is grown from the root node by evaluating ability to split a 
node using a random subset of all predictor variables. The split criteria are same as the criteria in 
CART algorithm (e.g. decrease of Gini Impurity, residuals sum of squares). After the bootstrap 
sample has been split at the top node, the splitting process is repeated and each tree is grown to 
its largest extent, for classification, the trees are grown until each terminal node contains 
members of only one class, while for regression they are grown until each terminal node contains 
same outcome value. These procedure is repeated many times to generate specified number of 
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trees (e.g. 100, 500, 1000, 5000, etc.). After all trees have been fully grown, training process is 
finished and the forest is formed (Figure 3). [59, 61, 76, 77] 
Each subject goes through each individual tree in the forest and get prediction result from 
each tree. Then the predictions of all trees are aggregated by majority voting to determine the 
class for classification problems or averaging each predictive value for regression problems.[43, 
59, 61, 68, 76, 77] The OOB samples also go through the individual trees they belong to and 
aggregate prediction results by majority voting or averaging. Then the RF prediction error could 
be assessed by OOB sample. The key to the accuracy of RF predictions is low bias and low 
correlation. Low bias is caused by averaging or voting prediction from large number of 
individual trees. During individual tree building process, the use of different bootstrap sample 
and randomly selection of a subset of predictor variables for consideration of split at each node 
result in low correlation among trees. If trees are not built by this two-way randomness, all 
individual trees will be similar with significant overfitting due to the largest extent in tree 
building process and therefore lead to poor future prediction while aggregating results from all 
trees.[59, 61] 
2.3.2 Prediction Accuracy 
In machine learning, a predictive model tends to overfit since the model is built by the training 
dataset but may result in low prediction accuracy in future use. Due to empirical relationship 
from training dataset, overfitting will be more apparent in complex model. A common way to 
assess overfitting is to use a separate testing dataset to estimate the model prediction accuracy. 
This may result in an undesirable small training dataset especially when the amount of whole 
sample is small. The second option is called cross-validation, which provides an assessment of 
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model performance without reducing the training data set and no need of an independent testing 
dataset. For example, in CART a 10-fold cross-validation is widely used. The original dataset is 
randomly assigned into 10 sub-datasets with equal sample size. Then one sub-dataset is used as 
the validation dataset for testing a tree trained by the other 9 sub-dataset. The process is then 
repeated 10 times, with each of the 10 sub-dataset used once as the validation dataset to produce 
the overall prediction error. 
RF has an inherent cross-validation process that internally validate model through OOB 
samples and average OOB error to yield overall prediction error for future prediction. When two-
thirds of the sample is randomly selected for building each individual tree, the remaining one-
third OOB sample is a validation dataset to estimate prediction accuracy for each tree, which is 
called the OOB error. The overall prediction accuracy of RF is estimated by averaging OOB 
error from all trees in the forest providing an overall estimate of the prediction accuracy.[49, 59, 
61, 76] 
In addition, in binary classification problems, the Receiver Operating Characteristic 
(ROC) curve is generated by plotting the false positive rate against true positive rate and area 
under the curve (AUC) values provide an indicator of the prediction accuracy and robustness of 
the model, which is similar to logistic regression.[78-80] 
 
2.3.3 Splitting Criteria 
The splitting rules in RF are: 1) decrease of Gini impurity for classification trees and, 2) 
minimizing residual sum of squares for regression trees, the most commonly used methods in 
CART. 
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In classification problem, to create a single tree in a RF, each split in the tree building 
process is started by measuring the impurity of the root node which defined as pi/t (probability 
that the outcome variable as class i) in Node t. A node with zero impurity consists of members 
belonging to in one class (e.g., all yes, or all death). The decrease of impurity function for a split 
is measured by the difference between the impurity in the parent node and the average impurity 
in the two child nodes. 
For a binary outcome (e.g. 0 or 1), decrease of Gini impurity can be calculated as 
follows:  
1. Calculate the Gini impurity function for the parent node (t): Gini impurity = 2pi/t(1 – 
pi/t). 
2. Calculate the Gini impurity for each of the two child nodes into which the parent node 
splits: Gini impurity for left child node = 2pi/l(1 – pi/l), Gini impurity for right child node = 
2pi/r(1 – pi/r). 
3. Calculate the weighted Gini impurity for two child nodes, according to the proportion 
of the parent node that is included in each child node (pl and pr): 
Weighted Gini impurity = (pl)( 2pi/l(1 – pi/l)) + (pr)( 2pi/r(1 – pi/r)), pl and pr refer to the 
proportions of the parent node that are included in the left and right child nodes. 
4. Calculate the decrease of Gini impurity, which is equal to the following: Decrease of 
Gini impurity = Gini impurity in parent node – weighted Gini impurity in two child nodes.  
Larger values of the decrease of Gini impurity indicate greater difference with respect to 
the class distribution of outcome in the two child nodes. The predictor variable whose split 
provides the largest value of the decrease of Gini impurity is selected for splitting at each node. 
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To demonstrate, consider a hypothetical example in which a parent node includes 100 
people from a case control study with a 50 cases of chronic pancreatitis (Y), which is the 
outcome variable. (Figure 4) Therefore, the impurity of the root node which defined as pi/t 
equals 0.5. Alcohol abuse (Yes or No) and smoking (Yes or No) are two candidate predictor 
variables to be evaluated to split the node. The alcohol abuse (X1) is first to split the parent node 
into two child nodes. The left child node which includes 60 people with alcohol abuse (X1=Yes) 
has 45 people with chronic pancreatitis. The right child node also includes 40 people without 
alcohol abuse (X1=No) has 5 people with chronic pancreatitis. In this situation, the Gini impurity 
is 0.5 for the parent node (Step 1: Gini impurity = 2*0.5*(1-0.5)). The Gini impurity is 0.375 for 
the left child node and 0.219 for right child node. (Step 2: Gini impurity for left child node = 
2*0.75(1 – 0.75), Gini impurity for right child node = 2*0.125(1 – 0.125)). Since the proportion 
of subjects included from the parent node is 0.6 in each child node and 0.4 in right child node, 
the weighted Gini impurity for two child nodes also equals to 0.313 (Step 3: Weighted Gini 
impurity = (0.6*0.375+0.5*0.219)). Then the decrease of Gini impurity is equal to 0.50 - 0.313 = 
0.187 (Step 4) using alcohol abuse to split parent node into two child nodes.  
Meanwhile, another predictor variable smoking (X2) is also tested to split the parent 
node. In the same way, the left child node which includes 70 smokers has 40 patients with 
chronic pancreatitis, and the right child node which also includes 30 non-smokers has 10 patients 
with chronic pancreatitis. Follow the same formula above, this time the Gini impurity is 0.49 for 
left child node and 0.44 for right child node. The weighted Gini impurity for two child nodes 
equals 0.475. Then the decrease of Gini impurity would be equal to 0.50 - 0.475 = 0.025 (Step 
4), which is much smaller compared to result using alcohol abuse to split (0.187). As a result, 
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this parent node will split using alcohol abuse (X1) into two child nodes because it has larger 
value for decrease of Gini impurity.  
For continuous predictor variable, the decrease of Gini impurity was evaluated for all 
possible values in this variable to find the optimal cut off value for split by this continuous 
predictor variable and then compare to other predictor variables including categorical and/or 
continuous variables. 
In regression problem, as we did for the linear model, minimizing residual sum of squares 
is used to decrease the impurity of node. Using this criterion, the best split at a node is the split 
on one of all variables which most successfully separates the high outcome value from the low 
outcome value in the parent node and therefore minimize residual sum of squares in two child 
nodes.[55] 
2.3.4 Variable Importance 
One of the key results from RF is that it measures the entire effect of all predictor variables 
because RF is able to integrate not only the main effects but also the interaction effects even 
though the variables with weak marginal effects. 
The RF methodology ranks the candidate variables with respect to their importance in 
predicting the outcome throughout the RF. It is determined by the mean difference of prediction 
accuracies observed for each tree using OOB error before and after random permutation of a 
predictor variable.[59, 61, 81] To illustrate, supposing a dataset of chronic pancreatitis study, 
those patients who drank alcohol more frequently per month (e.g. more than 15 days per month) 
are more likely to develop to chronic pancreatitis. However, randomly permuting the values of 
drinking frequency per month in all subjects should destroy this association. Subsequently, using 
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new OOB samples consisting permuted values for drinking frequency to predict whether a 
patient has chronic pancreatitis or not, the prediction accuracy will decrease since the more 
influential variables will have more occupancies of splits throughout the forest and the nodes 
split by drinking frequency will lead to wrong partitions after permutation. Therefore, a large 
decrease in prediction accuracy indicates a strong association between a predictor variable and 
the outcome because random permutation destroys their original relationship in OOB sample and 
lead to worse prediction error. Values around zero or even negative indicate that a variable is not 
important and no association with outcome because they are weak predictors with small chance 
to have a spot for split throughout the forest. The permutation process is repeated for all 
predictor variables and then their importance to the outcome can be ranked in terms of the 
difference in prediction accuracy between permutation OOB error and the original OOB 
error.[59, 61]  
As mentioned above, the variable importance measures in RF have ability to detect 
complex interactions between predictor variables because variables involve in specific 
interactions are likely to stand out as ‘important’. Random permutation in one variable should 
also destroy its interaction effects with other predictor variables to the outcome and as a result, 
the prediction accuracy decreases.[59] In addition, RF could capture important predictor variable 
correlated with other predictor variables. Because of random selection of small number of 
variables in split process, RF sometimes splits on one and sometimes on another correlated 
variables. Therefore, RF tends to identify all of the correlated predictors as important if any one 
of them are important.[59] 
There is a second measure available in RF to compute variable importance called Gini 
importance which is only used in classification problems.[49, 61, 77] The Gini importance of a 
 28 
variable is simply calculated by the sum of decrease of Gini impurity of the variable used to split 
a node throughout the entire forest. A more important predictor always has more splits in the 
forest with larger amount of decrease of Gini impurity, leading to a high Gini importance. 
However, a selection bias may occurs in Gini importance because of the randomly selected 
variables at each node in which Gini importance calculated with its occurrence of a predictor in 
the trees.[49, 76, 77] This selection bias does not affect the permutation importance because it is 
based on the decrease of prediction accuracy resulting from OOB sample. Even if unimportant 
predictors are selected for split due to the selection bias in tree building process, they do not have 
ability to significantly improve the overall OOB prediction accuracy, thus do not have higher 
permutation importance. Practically, however, Breiman said the Gini importance is often very 
consistent with the permutation importance method.[61] 
2.3.5 Proximities 
A special feature of RF is the calculation of proximities between each pair of subjects among 
samples.[43, 59, 82] After the forest is built, the proximity between two subjects could be 
calculated as the number of times the two subjects end up in the same terminal node of a tree in 
the forest, divided by the number of trees in the forest. Therefore, a proximity equals to 1 means 
two subjects always lie in the same terminal node across all trees while a proximity equals to 0 
means two subjects are never in the same terminal node. Repeated for all pairs of subjects over 
all terminal nodes in the forest, the proximity scores could generate a proximity matrix to 
demonstrate the degree of dissimilarity among subjects as well as to produce multidimensional 
scaling plots to visualize the distance between subjects typically in a two-dimensional plot.[83] 
The proximity plot could be used to reveal more hidden data structure, e.g. sub-clusters, outliers, 
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and mislabeled cases that could be of interest to the researchers. In addition, the proximity scores 
could be used to impute missing values.[59, 82] 
2.3.6 Missing Values 
RF could handle missing values in the predictor variables. During the tree building process, RF 
could simply impute missing values using the most frequent non-missing value for categorical 
variables or computing the median for continuous variables.[59, 61] 
Moreover, RF has an advanced method to give better imputation performance for missing 
values by integrating proximities mentioned above. After the forest is generated with simple 
missing value imputation, an adjusted missing value imputations are computed using a 
proximity-weighted majority frequency for categorical variables or a proximity-weighted 
average for continuous variables and then replace simply imputed values. After that, a new forest 
is built with new proximities and missing value imputations. It is suggested that repeat this 
process 4 – 6 times to optimize the imputations but however, this method is computationally 
expensive and seldom used.[59] 
2.3.7 Parameters 
RF analysis has two major parameters that are pre-specified: the number of variables to sample 
at each node (mtry), and the number of trees to build (ntree).[59, 61, 77] In addition, the class 
weight for classification trees and the tree size could also be adjusted but less commonly 
specified in practice. There is no optimal values for these parameters because they are data 
dependent. Since minimizing prediction error is the most important creation to judge the 
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performance of a RF model, the result of OOB error, which is the unbiased estimation of 
generalization error in RF, could be used to find optimal value of these parameters by running 
sensitivity analyses.[59, 61, 77] In practice, it has been shown that the RF are not very sensitive 
to these parameters.[59, 77] 
mtry 
At each node of an individual tree building process in RF, a small number of different 
subsets of variables is randomly selected from all predictor variables to find an optimal split 
(mtry).[77] Smaller values of the mtry may decreases the accuracy of each tree when there are a 
large number of noise predictor variables because a small subset of all variables may randomly 
select all noise predictors only thus leading to poor split and increasing the bias. However, when 
there are large number of less or moderate important predictor variables, small mtry may give 
them more opportunities to split and higher ranking in variable importance. The large mtry tends 
to decrease tree complexity because fewer variables will be used in trees and produce more 
correlated trees. There is no definite value of mtry as the optimal choice. The best choice is 
reflected by the prediction error calculated by OOB error. However, Breiman recommended a 
default value of mtry equals square root of total number of variables (√p).[61, 68, 76] 
ntree 
Another important parameter is how many trees to grow (ntree).  The number of trees in 
the forest should increase with the increase of number of candidate predictor variables, so that 
each predictor variable has more opportunities to be randomly selected to consider to split a 
node. But increasing ntree will lead to extra computation required. Breiman demonstrated that 
increasing the number of trees does not result in overfitting and a larger value of ntree always 
produces more reliable prediction ability compared to a smaller value.[59, 61] Thus, it is 
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recommended to increase the value of ntree and to stop increasing till OOB error is stable. It is a 
recommended to default value of ntree = 500 - 1000, which is large enough to produce a stable 
result with respect to OOB error. [49, 59, 61, 77] 
Class weight 
In some classification problems, the proportion of minority class in the sample may be 
extremely small, e.g., only 5% of population have a disease versus 95% of population healthy in 
a population. Generally, RF tends to minimize overall error rate, keep the error rate relatively 
low on the majority class while allowing the minority class to have a large error rate. However, 
the misclassification cost may be very high due to large proportion misclassified minority cases.  
RF offers a way to adjust the weights for each class to help to generate more balanced 
results in classification error for all classes for unbalanced data. The larger weight could be 
assigned to minority class to penalize its misclassification error rate. However, while getting this 
balance, the overall classification error rate will go up.[59] The best value of weight could be 
tested by trying different weights to accommodate the relatively balanced error rate among 
classes.  
There is another technique to deal with unbalanced data called “balanced” RF introduced 
by Chen et al, by down-sampling majority class in bootstrapping in each tree building process, 
drawing a bootstrap sample from the minority class and then randomly draw the same number of 
cases from the majority class.[84] 
Tree Size 
Limiting the size of individual trees does not often occur because in RF theoretically 
builds the largest extent unpruned trees. However, RF has the options to limit size of a tree, such 
as the maximum number of splits, the minimum number of cases in the terminal nodes. It may 
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save computation time and may or may not provide more reliable individual trees to provide 
lower overall errors. As same as other parameters, there are no optimal values and the overall 
OOB error is used to see if there are necessary to adjust on the model.[59, 77] 
2.4 APPLICATIONS OF RANDOM FORESTS IN EPIDEMIOLOGY 
RF has been successfully applied in genetic epidemiology especially with GWAS data.[48, 50, 
69, 70, 77] 
A study by Goldstein et al used RF analysis in a multiple sclerosis case-control study 
comprised of over 300,000 SNP genotypes in 931 patients and 2,431 controls.[68] Their results 
showed that a group of SNPs from a region in chromosome 6p were ranked as top important 
variables which were consistent with marginal chi-square statistics and the OOB error of RF was 
35%. After that, they removed all SNPs on chromosome 6p since association between these 
SNPs and the disease has been well established from previous findings. Therefore, RF analysis 
was performed again to search weaker effects after removing chromosome 6p SNPs. The new 
RF results were compared to findings from the previous study and new top 25 important 
variables on the ranking list were supported by them. In addition, four new interesting candidate 
genes were identified that strongly deserve further investigation.[68] 
Xu et al applied RF to the prediction of exacerbations in a population of childhood 
asthmatics participating in the Childhood Asthma Management Program.[70] The outcome of 
this study was an emergency room visit or a hospitalization for asthma symptoms during a four 
year follow-up period. There were 417 children enrolled in the study and 127 (~30%) of them 
experienced at least one severe asthma case. They used age, sex, pre-bronchodilator FEV1%, and 
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treatment group, and/or SNPs as predictors to predict severe asthma exacerbations.  To reduce 
time expense due to implementing all SNPs at a time in RF analysis, they first computed RF 
variable importance scores for all SNPs, 4,000 at a time in chromosomal order. Base on variable 
importance sores for all SNPs, then they selected the top 4,000 SNPs, and reran RF with these 
selected SNPs to re-rank them to generate a candidate gene ranking list. Then they ran RF 
analysis and repeated it with 4 clinical characteristics only, and clinical characteristics plus 
different numbers of SNPs selected based on variable importance score from previous candidate 
gene SNPs list as predictors. Instead of using OOB error, they used an independent testing 
sample and selected AUC as the indicator of prediction accuracy. With just the 4 clinical 
characteristics as predictors, the RF model had an AUC = 0.56. The AUCs were 0.57, 0.62, 0.66, 
and 0.66 in repeated RF models with clinical characteristics plus 10, 40, 160 and 320 SNPs, 
respectively, indicating that the severe asthma exacerbation in children is affected by genetic as 
well as environmental factors. They concluded that a reasonable prediction model of asthma 
exacerbations in children can be achieved through the combination of SNPs and clinical 
charactertics in a RF model and results improved the understanding of the biologic mechanisms 
behind why only certain individuals with asthma are at risk for exacerbations.[70] 
RF has been also used in other areas of epidemiology such as molecular 
epidemiology.[67, 71, 85] Barrett et al applied RF to classify samples from 76 breast cancer 
patients and 77 controls whose proteomic profile had been obtained using mass spectrometry and 
365 biomarkers detected from candidate predictor variables.[71] Based on the prediction from 
OOB samples in RF analysis, the overall OOB error rate was 16.3% and the importance of 
biomarkers were ranked. They used an independent sample to test and showed consistency in 
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terms of the performance and they concluded that the RF provides a high-performance 
classification system for proteomic data. 
Gurm et al evaluated prediction performance using RF analysis on risk of contrast-
induced nephropathy in patients undergoing contemporary percutaneous coronary 
procedures.[86] Since they had a very large study cohort with 68000 patients, they randomly 
selected approximately 48,000 patients to run RF analysis and 20,000 patients used as separate 
validation sample. The study had 46 baseline clinical variables used in RF analysis. All 46 
baseline variables were ranked by variable importance in RF and they selected 15 variables with 
the largest importance scores to build a reduced RF model. The full and reduced RF models were 
evaluated regarding to prediction accuracy in the validation sample. Predictive accuracy for full 
and reduced models were higher than 0.8. They concluded that this risk prediction model may 
prove useful for both clinical decision making and risk assessment.[86] 
2.5 PROBLEMS IN RANDOM FORESTS 
The primary limitation of RF is that the rank of variable importance does not specify the actual 
variable interactions, for example whether predictors have an effect in combination with other 
predictors and if yes with which.[76] Therefore, it is difficult to interpret since there is no 
information about the splits in each individual tree in the output of RF. 
Decision tree methods are well suited for non-linear modeling that help to identify 
conditional interactions, e.g. if a predictor variable is used as a split in a child node on left branch 
of the tree but not on the other branch which indicates an interaction effect between that variable 
and the variable in its parent node. As each individual tree is different from others in RF, the 
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overall variable importance score only provides the importance ranking of all predictor variables 
but does not specify the actual variable interactions. Moreover, in a situation where two 
interacted variables have no main effect, it is harder to interpret the interaction effect due to the 
lack of a marginally detectable main effect.[76] 
Second, variable importance provides a ranking of important predictor variables. 
However, it does not show the significance values of these predictors or a threshold to define 
which predictor should be selected for further interpretation. Variable importance always 
provides a ranking - even if all predictors are useless to the prediction problem. Some researches 
have investigated this issue but no formal approach has been adopted. Therefore, sometimes 
variable importance from RF analysis is hard to be interpreted due to the lack of inference 
threshold such as the p-value used in statistical analysis. 
In an exploratory study using RF, Strobl et al suggested that excluding variables whose 
importance is negative, zero or has a small positive value that lies in the same range as the 
negative values from further exploration by the rationale of random variation of the importance 
score around zero for unimportant variables. Therefore, positive values of importance score that 
exceed this range may indicate that a predictor variable is informative and worth for further 
investigation. [49] Díaz-Uriarte et al suggested to iteratively remove those variables with the 
smallest variable importance, typically the bottom 20% and re-run RF until prediction accuracy 
significantly decreases.[87] In a study by Goldstein et al, they used scree plot to visualize 
variable importance and chose the ‘elbow’ as the threshold to determine the important 
variables.[68] 
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2.6 UTILIZATIONS OF RANDOM FORESTS WITH OTHER APPROACHES 
While RF can successfully be used by itself, one of its greatest utilities comes in combination 
with other modeling approaches. Many authors have performed multistage analyses using RF as 
a first stage screening step and then followed up with other statistical analysis. 
In a study by Zyriax et al, baseline characteristics, and 41 SNPs that have previously been 
found to be associated with type 2 diabetes were analyzed by RF first to select the most 
important risk factors for contributing pre-diabetes. They found 3 baseline characteristics and 6 
SNPs are relatively important variables using the variable selection criteria suggested by Strobl. 
Then they performed logistic regression and found 3 SNPs was significantly associated with 
higher risk to pre-diabetes and 1 SNP was significantly associated with lower risk to pre-
diabetes, while other 2 SNPs showed a tendency towards a higher risk. However, In this paper, 
they did not evaluate interaction effects in the logistic regression model.[88] 
Jiang et al studied case-control data by first running a RF with all SNPs to obtain variable 
importance and then designing a sliding window sequential forward feature selection algorithm 
that could select a small group of candidate SNPs to minimize the classification error and then 
used a B statistic to test up to three-way interactions of the candidate SNPs.[51, 89] They named 
it as epiforest for the detection of epistatic interactions using RF. 
2.7 CONCLUSION 
The RF has become a very useful computational analytic algorithm in various research areas for 
both classification and regression problems. It has been applied in a number of epidemiological 
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researches especially in genetic epidemiology due to its capability to explore data structure and 
hidden information in large-scale data. The RF is a powerful analytic framework that help to 
analyze large dataset, e.g. variable importance evaluation, missing value imputation, outcome 
prediction, variable selection, etc. RF already has generated many successful applications in a 
variety of fields and contributed in many publications in last decades. However, RF still under 
investigation and expansion to be better understood by scientific researchers. Regarding to 
epidemiological researches, there are still many questions to utilize RF for analysis. The results 
from RF analysis is dramatically different from traditional statistical models such as the lack of 
p-values, confidence interval and statistical inference. The new perspective may hard to be 
interpreted in an epidemiological research. How stable the result is and how to combine RF and 
other analytic models to initiate more sophisticated data analysis are still questioned. Therefore, 
RF is a promising data analytic tool that need more exploration and its application in 




Figure 3. Random Forests Algorithm 
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 Figure 4. Example of Decrease of Gini Impurity 
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3.0  APPLICATION OF THE RANDOM FORESTS METHOD TO IDENTIFY 
IMPORTANT RISK FACTORS ASSOCIATED WITH DIFFERENT PAIN PATTERNS 
IN PATIENTS WITH CHRONIC PANCREATITIS 
3.1 ABSTRACT 
The abdominal pain is the most common clinical symptom in chronic pancreatitis (CP) patients. 
The expressions of pain in CP patients are highly variable and the causes are still under 
investigation. The mechanism of pain in CP patients is thought to be multifactorial and 
interactive. The present study is aimed to detect important factors that associated with 
developing different pain patterns (constant pain vs intermittent pain) in CP patients. Random 
Forests (RF) analyses were performed to analyze North American Pancreatic Study 2 - 
Continuation and Validation (NAPS2-CV) study, and was able to identify important risk factors 
associated with development of different temporal pain patterns in CP patients. Patients’ age at 
CP diagnosis, and two genetic variants rs10818187 and rs7894089 are the most important 
predictor variables to determine intermittent or constant pain in CP patients. The results 
confirmed that the complex mechanisms for development of pain in CP. The identification of 
these factors may be useful in clinical practice to identify individuals at risk for the constant pain 
at the early stage in CP. 
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3.2 INTRODUCTION 
Chronic pancreatitis (CP) is characterized pathological evidence of destruction of pancreatic 
tissue, ductal abnormality, fibrosis, inflammation, and loss of both endocrine and exocrine 
function.[2, 33] Abdominal pain is the principle symptom of CP because pain is the most 
common clinical symptom occuring in up to 90% of patients and accounts for repeated 
hospitalizations, interventions, narcotics addiction, detrimental effects on quality of life and 
medical costs associated with caring for these patients.[5, 32, 90] 
Pain in CP is most often located in the upper abdomen. It is sometimes extended to a 
other parts of the abdomen and radiated to the back.[35] However, the expressions of pain in CP 
patients are highly variable in severity, frequency and features, and have been challenging to 
physicians.[32, 91] Temporality and severity of pain are the most two common ways to 
characterize the pain patterns in CP. 
Pain is CP patients may be intermittent and/or constant, mild, moderate and/or severe. 
Pain may express in different forms, ranging from those patients with no or little mild pain to 
those with continuous severe pain.[34] There is no universal pain pattern in CP even in similar 
status of the destruction of pancreas. But it is usual that pain is deep, penetrating and debilitating, 
and the extent may increase after eating.[35] Moreover, the pattern of pain may change over time 
in the same patient. 
Mullady et al. analyzed the relationship between pain pattern and the disease burden 
associated with pain using a national cohort study of North American Pancreatitis Study-2 
(NAPS2).[24, 32] They classified a total of 414 CP patients with pain regarding to their pain 
status with respect to temporality pattern (intermittent vs. constant pain), and severity pattern 
(mild/moderate vs. severe pain). They found that patients who experienced constant pain had 
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higher rates of disability, hospitalization, use of pain medication and lower quality of life 
compared to patients with intermittent pain patterns. In contrast, there were no significant 
associations between the quality of life and the difference in severity of pain.[32] Therefore, it 
has been suggested that management of relapse of pain is more important than relieving severe 
pain in CP patients which indicates that the evaluating determinants associated with the constant 
pain might be much more meaningful to clinical practice in management of pain in CP. 
The mechanisms of pain in CP continue to be investigated. There are no significant 
associations between imaging findings or function testing and different pain patterns from 
previous studies.[35] Most current theories are linked to peripheral and central nociceptive nerve 
sensitization, that may be motivated by repeated episodes of inflammation and pancreatic 
injury.[34] But the cause of pain in CP patients is thought to be multifactorial and interactive 
because the mechanism of development of CP is very complex. As was mentioned earlier, pain 
patterns are variable in CP patients with similar injury to the pancreas, which indicates that 
genetic factors may contribute to different pain patterns in CP patients. Based on existing 
literatures, there are no evidence of the role of genetics on pain patterns. 
The present study is aimed to detect important factors that associated with developing 
different pain patterns (constant pain vs intermittent pain) in CP patients. 
3.3 MATERIALS AND METHODS 
Study Population 
Study subjects and data were derived from the North American Pancreatic Study 2 - 
Continuation and Validation (NAPS2-CV) study, a cross-sectional and observational follow-up 
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study. The original North American Pancreatic Study 2 (NAPS2) was a multicenter, molecular 
epidemiology study designed to understand the underlying environmental, metabolic, and genetic 
factors associated pancreatitis. Between August 2000 and September 2006, 1,000 human subjects 
with recurrent acute pancreatitis (RAP) or CP, plus 695 controls were ascertained and the study 
data has been used to conduct many genetic and gene-environment studies for CP and RAP.[24] 
In 2008, the NAPS2-CV was funded to continue the work started by original NAPS2. The goal 
of NAPS2-CV was to collect a validation group of European ancestry subjects for potential 
genome-wide association studies (GWAS) and there were 521 CP patients recruited. 
In NAPS2-CV, all patients described their pain features of two kinds of abdominal pain - 
constant and/or intermittent pain patterns in two separate pain questionnaires using newly 
developed McGill pain short form.[92] Some patients having one of two pain patterns filled out 
one of two questionnaires, while some patients filled out neither or both. Since the study 
objective was to identify important predictor variables that contribute to different temporal 
pattern of abdominal pain. We included CP patients with either constant pain or intermittent pain 
only to extract eligible subjects from all CP patients in NAPS2-CV. Therefore, the outcome of 
interest was pain pattern status classified as constant pain or intermittent pain. In NAPS2-CV, 
study subjects were also asked to assess the temporality and severity of their pain based on 
recommendations of the American Gastroenterological Association (AGA) which was used in 
original NAPS2 study and successfully evaluated in previous study.[32] As a result, the 
classification of temporality of pain in CP patients in NAPS2-CV could be summarized by two 
separate ways and we used sample of patients whose pain patterns classified by AGA 
recommendations as validation for current study. 
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Demographic and Clinical Variables 
The following candidate predictor variables were selected or calculated from NAPS2-CV 
questionnaires for evaluation. Patient’s gender, race, ethnicity (Hispanic or Latino), Ashkenazi 
Jewish heritage, family history of any pancreatic disease, family history of AP, family history of 
CP, family history of pancreatic cancer, patient history of AP, additional attacks of AP, age of 
CP diagnosis, alcohol consumption during the period of maximum drinking in patient’s lifetime 
(abstainer, light drinker, moderate drinker, heavy drinker or very heavy drinker), alcohol 
consumption in the months before getting pancreatitis, smoking (non-smoker, former smoker, 
current smoker), amount of smoking (none, less than 1 pack per day, more than 1 pack per day), 
exocrine insufficiency, endocrine insufficiency, TIGAR-O etiologic risk factors including any 
toxic-metabolic factor, alcohol, tobacco, hyperlipidemia, hypercalcemia, medications, chronic 
renal failure, toxins, idiopathic factors, any genetic factor, Cationic Trypsinogen mutation, CFTR 
mutations, SPINK1 mutations, Alpha 1-antitrypsin deficiency, other genetics, any autoimmune 
pancreatitis (AIP) factor, Sjogren’s disease, rheumatoid arthritis, primary sclerosing cholangitis 
(PSC), retroperitoneal fibrosis, other AIP, any autoimmune disease-associated factor, Crohn’s 
disease, ulcerative colitis, autoimmune hepatitis, other autoimmune disease-associated factors, 
any recurrent and severe acute pancreatitis associated chronic pancreatitis factor, postnecrotic, 
postirradiation, vascular diseases/ischemic, any obstructive factor, pancreas divisum, sphincter of 
oddi disorders, posttraumatic pancreatic stricture, preampullary duodenal diverticulum, duct 
obstruction, pancreatic cancer, intraductal papillary mucinous neoplasm (IPMN), other 





DNA was isolated from patient blood samples using the Qiagen FlexiGene DNA Kit 
(Qiagen Inc, Valencia, CA, USA).[93] Genotyping was performed at the University of Pittsburgh 
Genomics and Proteomics Core Laboratories using the MassARRAY iPLEX GOLD (Sequenom, 
Inc, San Diego, CA, USA). The gene polymorphisms of 58 candidate SNPs (Table 1) that may 
associated with chronic pain in CP identified from the first stage GWAS in NAPS2 study were 
included in analysis.[40] 
3.4 ANALYSIS 
Descriptive analyses for all predictor variables between two pain pattern groups were reported as 
means and standard deviation for quantitative variables or count and proportions for categorical 
variables. All genetic variables were analyzed as binary categorical variables with common allele 
homozygotes treated as reference group. Bivariate comparisons for continuous variables were 
performed using Student’s t-test or Mann–Whitney U test and for categorical variables using chi-
squared tests or Fisher’s exact tests, as applicable. 
Random Forests (RF) analysis was used to identify important risk factors in all 117 
candidate predictor variables associated with the temporal pain patterns in patients with CP. RF 
is an ensemble of large amount of individual decision trees by randomly selecting a bootstrap 
subset sample of two-thirds of whole sample per tree and randomly selecting a subset of all 
predictor variables at each node of the tree. At each node, RF selects the predictor variable that 
best splits data into two child nodes.[61] This process allows for all demographic, clinical and 
genetic factors to work simultaneously in predicting the pain patterns in CP patients. RF 
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determines classification error using the out of bag sample (OOB), those one-thirds of subjects 
not randomly selected to build a given individual tree. RF works through this process of selecting 
bootstrap samples to build the tree and using the OOB samples to determine error and variable 
importance. The variable importance was evaluated using permutation importance. The given 
variable was randomly permuted in the OOB sample for the tree and new estimate of OOB error 
was calculated. All candidate predictor variables in the model were ranked based on the 
difference between this estimate and the original OOB error. The larger increase in classification 
error indicates a stronger association between a given predictor variable and the pain patterns 
because random permutation destroys their original relationship in OOB sample and lead to 
worse classification error.  
To address clinical question that help physicians to determine if a CP patient at risk of 
having constant pain patterns, a set of predictor variables and preferably small set of predictor 
variables were expected to be identified using RF analysis. An iterative RF analysis framework 
was used to identify and select important variables for further examination. To build the 1st RF, 
we used all variable without pre-selection to get the ranking of variable importance. Based on the 
recommendation by Díaz-Uriarte et al,[87] the bottom 20% of variables with the lowest 
importance score were dropped and a new RF was built. This process was repeated till there 
were two variables left to evaluate in the final RF analysis. After building all RF, The OOB error 
from all RF were evaluated. In steading of selecting the best model, our purpose is to use RF 
analysis to help us to select a relatively less complex and parsimonious model with minimum 
number of predictor variables which performs not significantly worse than the best model 
regarding to the classification accuracy (OOB error). Therefore, if there is a RF with smaller 
number of variables and the OOB error is not significant higher than the RF with the lowest 
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OOB error, its set of variables was selected for further investigation. The important variables 
found in these best models were analyzed in a multivariable logistic regression model to estimate 
the association among the set of identified predictor variables and the pain patterns. The area 
under the receiver operation characteristic (ROC) curve (AUC) from logistic regression model 
was evaluated to examine model discrimination abilities. Typically, an AUC value of 0.5 means 
a model accuracy of 50% in predicting positives and is no better than the random assignment of 
positive or negative status. An AUC value of 1.0 shows the model accurately classified 100%. If 
AUC exceeds the critical value of 0.7, the model is considered with high predictive power.[94] 
To compare the model using the optimal combination of predictor variables selected from RF 
analysis, a logistic regression using stepwise variable selection procedure for all 117 candidate 
variable was performed to identify important predictor variables associated with the difference in 
temporal pain patterns in CP.  
To validate the results using new adopted McGill short pain form for classifying 
intermittent and constant pain groups, the sample of CP patients in NAPS2-CV whose temporal 
pain patterns classified by AGA recommendations was used as validation dataset. The samples 
were not mutually exclusive because patients might filled out both pain pattern questions in 
NAPS2-CV. The validation sample was scored in the logistic regression model concluded from 
RF analysis to compare the difference in classification ability using AUC statistic. If 
classification ability were similar then it could be shown that the pain pattern classification using 
McGill short pain form are parallel to original AGA recommendation pain pattern classification 
system and the results from the current study were valid. 
RF analyses were implemented in Salford Predictive Modeler, version 7.0 (Salford 
Systems, San Diego, CA). The RF analyses were implemented with the recommended parameter 
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settings: the number of trees was set to ntree=1000; the number of variables to test at each node 
was set to mtry=√N (N=Total number of variables used in each RF). The OOB error was 
generated for each RF analysis and the variable importance score was calculated by permutation 
importance method. 
Multivariate logistic regression models were built using the most promising variables 
found in RF analysis and odds ratio (OR) with 95% confidence interval (CI) were calculated. 
Descriptive and logistic regression analysis were performed using SAS, version 9.3 (SAS, Inc., 
Cary, NC). 
3.5 RESULTS 
In NAPS2-CV study, intermittent pain characters were reported by 323 of the 521 CP patients 
enrolled (62.0%) and constant pain characters were reported by 260 of the 521 CP patients 
enrolled (50.0%) based on Short Form McGill Pain Questionnaire. Among them, 173 were 
patients with intermittent pain only, and 110 were patients with constant pain only. 150 patients 
with both pain patterns were excluded from the current study. Due to availability of genetic 
variants data, a total of 181 patients were enrolled for the analysis with 112 patients classified as 
intermittent pain group and 69 patients classified as constant pain group. 
The distribution of all demographic and clinical candidate variables were presented in 
Table 2. The initial RF analysis was implemented using all these predictor variables to build up 
the forest. The OOB error rate equals 0.3702 in classifying two pain patterns in CP patients, 
which means the overall classification accuracy of the 1st RF is 63.0%. All variables were 
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assigned an importance score with 58 of 117 variables have score higher than 0. The rest 59 
variables got score of 0 or lower. 
The second RF was analyzed by dropping 20% (n=23) of all variables with lowest 
importance score in the first iteration of RF. A total of 94 variables was kept to run the second 
RF analysis and a new ranking of variable importance was generated and the new OOB error rate 
equals 0.3812. Iteratively, a total of 18 RFs was built by removing the weakest 20% of variables 
from the previous ranking of variable importance. The 18th RF only contained 2 variables: age at 
diagnosis of CP and a SNP rs10818187. All OOB error rates and number of variable used for 18 
RF analyses are listed in Table 3 and the OOB error rate curve from the 1st RF to the 18th RF is 
presented in Figure 5. The 8th RF model with 24 variables has the relatively lowest OOB error 
0.2541 which means the highest classification accuracy generated by the 8th RF. The ranking of 
variable importance to classify two pain patterns in CP patients from the 8th RF model is listed 
in Table 4. Among 24 variables, age at CP diagnosis and SNP rs10818187 have relatively higher 
importance scores (16.52 and 16.45, respectively) compared to other 22 variables. The 
distributions of genetic variants in the 8th RF model were presented in Table 5. 9 of 24 variables, 
Age at CP diagnosis, rs10818187, rs10108543, rs7438388, rs7338234, rs7894089, rs465189, 
rs7389298, and Sphincter of Oddi disorders risk factor are univariately associated with two pain 
patterns in CP patients. rs10818187, rs10108543, rs7438388, rs465189, rs7389298, and 
Sphincter of Oddi disorders risk factor are significantly associated with higher risk of having 
constant pain in CP patients. Increased age at CP diagnosis, rs7338234, and rs7894089 are 
significantly associated with lower risk having constant pain in CP patients. 
From 8th to 17th RF analysis, the OOB error rate is fluctuated between 25.41% and 
28.73%. However, the OOB error rate of the 18th RF sharply increased from 28.18% in the 17th 
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RF analysis to 32.60% after dropping the 3rd as well as the weakest variable rs7894089 from the 
17th RF analysis, which means rs7894089 is an informative predictor variable that should be 
included in the model to help to correctly classify or predict pain patterns in CP patients. The 
variable importance score in the 17th are listed in Table 6. According to the 17th RF model, age 
at CP diagnosis, rs10818187, and rs7894089 represent the most powerful risk factors to 
determine the temporal pain patterns in CP patients. A multivariable logistic regression was 
performed including three variables. There was no interaction existing amongst three 
predictors.(Table 7) The results showed that age at CP diagnosis (OR for 10 years 
increase=0.776, CI 0.651-0.961, p=0.02) and rs7894089 (OR=0.394, CI 0.174-0.896, p=0.03) are 
significantly associated with the lower risk for constant pain, whereas rs10818187 (OR=2.603, 
CI 1.139-5.951, p=0.02) is a significant risk factor associated with the increased risk of having 
constant pain in CP patients (Table 8). The AUC equaled to 0.706 which indicates that the 
logistic regression model has good discrimination ability. 
The result from logistic regression using stepwise variable selection procedure (P < 0.30 
for entry in the model and P > 0.35 for removing the variables) for all 117 variables showed that 
no variable should be included and therefore no model was built through stepwise selection. 
The validation sample contained 105 intermittent pain CP patients and 166 constant pain 
patients. The validation sample was scored using 3-predictor logistic regression model and the 
AUC was 0.685 which indicated the two pain classification system are parallel. 
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3.6 DISCUSSION 
Abdominal pain is the most common symptom in CP and still remained as a major clinical 
challenge. Different pain patterns have been described previously and the constant pain is 
significantly associated with poor quality of life in CP patients.[32] There are some 
neurobiological theories proposed to understand pain in CP. Also, it was hypothesized that 
differences in pain patterns are related with different etiology of CP but has not been 
confirmed.[95] The etiology of pain in CP is likely involves multiple mechanisms. However, the 
studies on the influence of multiple factors including demographic, clinical, and genetic variables 
to the determination of pain patterns in CP patients is still limited. 
Because previous findings showed that patients who experienced constant pain had 
higher disease burden and lower quality of life compared to patients with intermittent pain 
patterns, we developed a backward elimination RF analysis framework combined with follow-up 
logistic regression model to identify important factors associated with different temporal pain 
patterns in CP patients. In high dimensional data, there might be a large number of uninformative 
predictor variables. Therefore, it is possible to see that in RF analyses if number of candidate 
predictor variables decreases, the OOB error will be lower because in tree building process with 
a large amount of candidate predictor variables, the random selection of a small subset of 
variables maybe all uninformative variables that lead to poor performance in some node split of 
the tree. Without variable pre-selection, results from iterations of RF analyses identified 24 
predictor variables are potentially related to the determination of different temporal pain patterns 
in CP patients regarding to the lowest OOB error using these variables together. These variables 
include patients’ age at diagnosis, their smoking status, alcohol drinking categories, family 
history of AP, and Sphincter of Oddi disorders, and a group of genetic variants. Alcohol drinking 
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and smoking are well established risk factors for development of CP but their relationships with 
pain patterns were not described previously. Sphincter of Oddi disorders is an obstructive 
etiology of CP. These result could be used as an evidence that the variant manifestations of 
different pain patterns in CP patients are extremely complex and likely involved multiple 
mechanisms and predisposing factors suggested by many studies focusing on pain in CP. Among 
24 variables, Age at CP diagnosis, rs10818187, rs10108543, rs7438388, rs7338234, rs7894089, 
rs465189, rs7389298, and Sphincter of Oddi disorders are significantly associated with the 
difference in pain patterns using traditional univariate statistical analysis. All these 9 significant 
variables are ranked the on the top in the variable importance list generated in RF. Sphincter of 
Oddi disorders risk factor is the lowest among these factors with the 15th ranking apparently due 
to its rare occurrence in the sample. Other 13 non-significant factors may involve in conditional 
interaction or serve as mediators with other factors in the context of complex mechanisms of 
pain in CP. 
A reduced RF model incorporating the most three important factors, the patients’ age at 
CP diagnosis, rs10818187, and rs7894089, has an OOB error of 0.28, which is slightly higher 
than the RF model with lowest OOB error (0.25). Regarding to the simplicity consideration, the 
results from this small RF analysis could be more meaningful for clinical purpose. The age at CP 
diagnosis is ranked as the 1st with importance score of 41.64 which indicated age is the most 
important predictor variable to classify CP patients with different temporal pain patterns. The 
2nd is rs10818187 and the 3rd is rs7894089 (importance score: 36.58, 21.77, respectively).  
In a logistic regression model, the 3 selected risk factors variables were all significantly 
associated with different pain patterns. The larger the age of CP diagnosis, the probability of 
intermittent pain increases in patients. Specifically, we estimated that the odds for having 
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constant pain in CP patients decrease 23% for each 10 years increase of age (10-year OR = 1-
0.97510 = 0.23) after adjusting for rs10818187 and rs7894089. The rs10818187 is a risk genetic 
variant (OR=2.603) of having constant pain whereas the rs7894089 is a protective genetic variant 
(OR=0.394) to having constant pain in CP patients. The SNP rs10818187 is inter-genic region 
between LOC389787 and DBC1 gene and rs7894089 located in FAM53B gene. To our 
knowledge, identification of these genetic variants has not been previously reported to relate to 
pain patterns in CP. In addition, other SNPs identified in the RF model with the lowest OOB 
error should also be investigated for the association with pain patterns because they may have 
complex interaction effects with other environmental, metabolic, and genetic factors. Therefore, 
further investigation is required to confirm the findings from current study. 
In addition, it was notably that performing stepwise logistic regression failed to build a 
model with one or more predictor variables to classify pain patterns in CP. The reason was that 
there were a number of variables with large number of missing value and the listwise deletion of 
incomplete subjects was used in stepwise regression modeling which resulted in small number of 
sample size and the loss of power to detect associations. However, in RF analysis, the missing 
values were automatically imputed using the most frequent –non-missing value or median. 
Missing value is frequently happened in high-dimensional data. The current study demonstrated 
the advantage of RF to handling missing value and therefore successfully identify important 
predictor variables for modeling purpose. 
The key findings from this study showed that using RF analyses, we successfully 
identified risk factor associated with having constant pain vs intermittent pain in CP patients. 
Analysis of the NAPS2-CV data indicates that using SNPs rs10818187, rs7894089, and the 
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patients’ age at CP diagnosis could be reliably used to make a distinction between intermittent 
and constant pain patterns in patients who suffer abdominal pain after diagnosis of the CP. 
3.7 LIMITATIONS 
A number of limitations of this study should be addressed. First, RF did not provide visual 
information about variable interactions even though it takes into account complex interaction 
effects in decision tree building process. The variables in the ranking of variable importance may 
have interaction effects with others but they were not specified. Second, the variable importance 
ranking in RF does not have a threshold to show evaluate the significance of importance which 
made them hard to interpret from a statistical perspective and make the decision on variable 
selection difficultly. Third, there was no formal way to select the optimal RF model, we selected 
a parsimonious RF model as the optimal model followed by statistical analysis based on its 
simplicity for clinical purpose. Finally, the sample size was relatively small and therefore the 
association between all candidate predictor variables and pain patterns may not be truly reflected. 
3.8 CONCLUSIONS 
We used RF analyses to analyze NAPS2-CV data, and was able to identify important risk factors 
associated with temporal pain patterns in CP patients. The results confirmed that the complex 
mechanism for development of pain in CP. Patients’ age at CP diagnosis, and two genetic 
variants rs10818187 and rs7894089 are the most important predictor variables to determine 
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intermittent or constant pain in CP patients. The identification of these factors may be useful in 
clinical practice to identify individuals at risk for the constant pain at the early stage in CP. In the 
future, more research is required to confirm these findings to establish a clinically applicable 
tool. 
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3.9 TABLES AND FIGURES 
Table 1. 58 Candidate pain SNPs 
SNP Chromosome Minor Allele SNP Chromosome Minor Allele 
rs4143111 1 A rs757323 7 G 
rs4927113 1 G rs2129557 7 A 
rs7540125 1 A rs10108543 8 G 
rs887958 2 A rs382796 8 A 
rs1001763 3 A rs1010587 9 A 
rs16861588 3 G rs10818187 9 A 
rs4698390 4 A rs7389298 9 G 
rs7438388 4 G rs7894089 10 G 
rs10017798 4 C rs4757031 11 A 
rs10009455 4 G rs17132911 11 A 
rs13127102 4 A rs7949201 11 G 
rs10461324 4 A rs516226 11 A 
rs7293455 5 G rs528431 11 A 
rs172139 5 G rs10492094 12 A 
rs10042680 5 A rs2302604 12 A 
rs17318106 5 A rs11055087 12 A 
rs13182765 5 A rs17394079 12 A 
rs1796520 6 G rs10506053 12 G 
rs1796521 6 A rs12582707 12 G 
rs1624440 6 G rs3741658 12 G 
rs9295689 6 G rs2050500 13 A 
rs2172007 6 C rs7338234 13 A 
rs2498399 6 G rs7317522 13 A 
rs1778296 6 C rs10146989 14 A 
rs2504284 6 A rs8029816 15 A 
rs1542650 6 G rs1551355 17 A 
rs721025 6 A rs4804524 19 G 
rs13214367 6 G rs465189 21 A 










Age at CP diagnosis, mean (SD) 50.07 (17.83) 43.37 (13.58) 0.0022 
Gender, n (%)    
Male 55 (56.12) 43 (43.88) 0.0832 
Female 57 (68.67) 26 (31.33)  
Ethnicity, n (%)    
Not Hispanic or Latino 111 (62.01) 68 (37.99) 1 
Hispanic or Latino 1 (50.00) 1 (50.00)  
Race, n (%)    
White 112 (62.22) 68 (37.78) 0.38 
Unknown 0 (0) 1 (100)  
Jewish heritage, n (%)    
No 2 (33.33) 4 (66.67) 0.1627 
One parent 108 (62.79) 64 (37.21)  
Both Parents 2 (100) 0 (0)  
Unknown 0 (0) 1 (100)  
Drinking category in maximum 
period, n (%) 
   
Abstainer 20 (64.52) 11 (35.48) 0.3256 
Light 23 (60.53) 15 (39.47)   
Moderate 17 (80.95) 4 (19.05)   
Heavy 25 (65.79) 13 (34.21)   
Very heavy 25 (54.54) 13 (34.21)   
Drinking category in period 
before pancreatitis, n (%) 
   
Abstainer 11 (84.62) 2 (15.38) 0.5093 
Light 21 (77.78) 6 (22.22)   
Moderate 10 (65.20) 6 (37.50)   
Heavy 11 (68.75) 5 (31.25)   
Very heavy 20 (62.50) 12 (37.50)   
Smoking, n (%)    
Never 38 (66.67) 19 (33.33) 0.0943 
Past 32 (71.11) 13 (28.89)  
Current 42 (53.16) 37 (46.84)   
Amount of smoking, n (%)    
Never 38 (66.67) 19 (33.33) 0.1757 
<1 pack/day 36 (67.92) 17 (32.08)   
≥1 pack/day 38 (53.52) 33 (46.48)   
Diagnosis of acute pancreatitis, 
n (%) 
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Yes 75 (67.57) 36 (32.43) 0.6471 
No 26 (60.47) 17 (39.53)  
Unknown 4 (57.14) 3 (42.86)  
Family history of any 
pancreatitis, n (%) 
   
No 85 (64.39) 47 (35.61) 0.3864 
Yes 15 (55.56) 12 (44.44)  
Family history of chronic 
pancreatitis, n (%) 
   
No 97 (60.63) 63 (39.38) 0.3379 
Yes 15 (71.43) 6 (28.57)  
Family history of acute 
pancreatitis, n (%) 
   
No 103 (64.38) 57 (35.63) 0.0563 
Yes 9 (42.86) 12 (57.14)  
Family history of pancreatic 
cancer, n (%) 
   
No 102 (60.71) 66 (39.29) 0.1283 
Yes 10 (76.92) 3 (23.08)  
Age at AP diagnosis, mean (SD) 43.96 (20.09) 41.13 (15.11) 0.3357 
Additional attacks of AP, n (%)    
No 47 (55.29) 38 (44.71) 0.0962 
Yes 64 (67.37) 31 (32.63)  
Exocrine insufficiency, n (%)    
No 61 (63.54) 35 (36.46) 06244 
Yes 51 (60.00) 34 (40.00)  
Endocrine insufficiency, n (%)    
No 66 (58.93) 46 (41.07) 0.2979 
Yes 46 (66.67) 23 (33.33)  
TIGAR-O etiologies    
Toxic-metabolic factors, n (%)    
No 38 (67.86) 18 (32.14) 0.2677 
Yes 74 (59.20) 51 (40.80)  
Alcohol, n (%)    
No 70 (64.81) 38 (35.19) 0.3225 
Yes 42 (57.53) 31 (44.93)  
Smoking, n (%)    
No 55 (67.90) 26 (32.10) 0.0953 
Yes 54 (55.67) 43 (44.33)  
Hyperlipidemia, n (%)    
No 81 (57.04) 61 (42.96) 0.1565 
Yes 20 (71.43) 8 (28.57)  
Hypercalcemia, n (%)    
No 97 (58.43) 69 (41.57) 0.5868 
Yes 1 (100) 0 (0)  
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Medications, n (%)    
No 97 (59.15) 67 (40.85) 0.3682 
Yes 1 (33.33) 2 (66.67)  
Chronic Renal Failure, n (%)    
No 97 (58.79) 68 (41.21) 0.4312 
Yes 2 (66.67) 1 (33.33)  
Toxins, n (%)    
No 98 (58.68) 69 (41.42) . 
Yes 0 (0) 0 (0)  
Idiopathic factors, n (%)    
No 76 (58.91) 53 (41.09) 0.2625 
Yes 34 (68.00) 16 (32.00)  
Genetic factors, n (%)    
No 94 (60.65) 61 (39.35) 0.5728 
Yes 16 (66.67) 8 (33.33)  
Cationic Trypsinogen mutation, 
n (%) 
   
No 101 (61.59) 63 (38.41) 0.2879 
Yes 5 (62.50) 3 (37.50)  
CFTR mutation, n (%)    
No 98 (60.49) 64 (39.51) 0.1575 
Yes 9 (75.00) 3 (25.00)  
SPINK1 mutation, n (%)    
No 103 (60.95) 66 (39.05) 0.5685 
Yes 3 (75.00) 1 (1.49)  
Alpha 1-antitrypsin deficiency, 
n (%) 
   
No 103 (60.95) 66 (39.05) 0.6118 
Yes 1 (100) 0 (0)  
Other genetic factors, n (%)    
No 103 (60.95) 66 (39.05) 0.4794 
Yes 1 (50.00) 1 (50.00)  
Autoimmune Pancreatitis, n 
(%) 
   
No 106 (61.27) 67 (38.73) 0.3226 
Yes 4 (66.67) 2 (33.33)  
Sjogren’s disease, n (%)    
No 108 (61.02) 69 (38.98) 0.6124 
Yes 1 (100) 0 (0)  
Rheumatoid Arthritis, n (%)    
No 106 (60.57) 69 (39.43) 0.2272 
Yes 3 (100) 0 (0)  
PSC, n (%)    
No 109 (61.24) 69 (38.76) . 
Table 2 Continued 
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Yes 0 (0) 0 (0)  
Retroperitoneal fibrosis, n (%)    
No 109 (61.24) 69 (38.76) . 
Yes 0 (0) 0 (0)  
Other AIP, n (%)    
No 109 (61.24) 69 (38.76) 0.6145 
Yes 1 (100) 0 (0)  
Autoimmune disease-associated 
factors?, n (%) 
   
No 106 (61.27) 67 (38.73) 0.3226 
Yes 4 (66.67) 2 (33.33)  
Crohn’s disease, n (%)    
No 108 (61.63) 68 (38.64) 0.4774 
Yes 1 (50.00) 1 (50.00)  
Ulcerative Colitis, n (%)    
No 109 (61.24) 69 (38.76) 0.6145 
Yes 1 (100) 0 (0)  
Autoimmune hepatitis, n (%)    
No 109 (61.24) 69 (38.76) . 
Yes 0 (0) 0 (0)  
Other AI disease, n (%)    
No 107 (61.14) 68 (38.86) 0.4395 
Yes 2 (66.67) 1 (33.33)  
Recurrent and Severe Acute 
Pancreatitis Associated, n (%) 
   
No 103 (62.80) 61 (37.20) 0.1414 
Yes 6 (42.86) 8 (57.14)  
Postnecrotic, n (%)    
No 104 (62.28) 63 (37.72) 0.1348 
Yes 5 (45.45) 6 (54.55)  
Postirradiation, n (%)    
No 108 (61.02) 69 (38.98) . 
Yes 0 (0) 0 (0)  
Vascular Diseases / ischemic, n 
(%) 
   
No 108 (61.02) 69 (38.98) . 
Yes 0 (0) 0 (0)  
Obstructive factors, n (%)    
No 84 (60.43) 55 (39.57) 0.6009 
Yes 26 (65.00) 14 (35.00)  
Pancreas Divisum, n (%)    
No 95 (60.90) 61 (39.10) 0.8004 
Yes 11 (57.89) 8 (42.11)  
Sphincter of Oddi disorders, n 
(%) 
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No 105 (62.13) 64 (37.87) 0.0090 
Yes 0 (0) 5 (100)  
Posttraumatic pancreatic 
stricture, n (%) 
   
No 103 (59.88) 69 (40.12) 0.3628 
Yes 2 (100) (0)  
Preampullary duodenal 
diverticulum, n (%) 
   
No 105 (60.34) 69 (39.66) . 
Yes 0 (0) 0 (0)  
Duct obstruction, n (%)    
No 100 (59.88) 67 (40.12) 0.2672 
Yes 5 (71.43) 2 (29.57)  
Pancreatic cancer, n (%)    
No 105 (60.34) 69 (39.66) . 
Yes 0 (0) 0 (0)  
IPMN, n (%)    
No 105 (60.34) 69 (39.66) 0.6057 
Yes 1 (100) 0 (0)  
Other obstructive, n (%)    
No 96 (58.90) 67 (41.10) 0.0485 
Yes 12 (85.71) 2 (14.29)  
Gallstones, n (%)    
No 108 (61.02) 69 (38.98) 0.1436 
Yes 4 (100) 0 (0)  
Miscellaneous factors, n (%)    
No 95 (60.51) 62 (39.49) 0.4887 
Yes 15 (68.18) 7 (31.82)  
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 Table 3. Number of variables and OOB error rate of each RF analysis 
RF analysis Number of variables OOB error (%) 
1 117  37.02 
2 94  38.12 
3 75  35.36 
4 60  29.28 
5 48  29.28 
6 38  30.39 
7 30  27.07 
8 24  25.41 
9 19  27.07 
10 15  28.73 
11 12  28.73 
12 10  27.62 
13 8  28.73 
14 6  28.18 
15 5  27.07 
16 4  28.18 
17 3  28.18 
18 2  32.60 
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 Figure 5. OOB error rate curve for all RF analyses 
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 Table 4. Variable importance score in the 8th RF 
Rank Variables VI 
1 Age at CP diagnosis, mean (SD) 16.52 
2 rs10818187, n (%) 16.45 
3 Age at AP diagnosis, mean (SD) 7.28 
4 rs10108543, n (%) 6.72 
5 Drinking category in period 
before pancreatitis, n (%) 
6.55 
6 rs7438388, n (%) 6.18 
7 rs7338234, n (%) 6.01 
8 Smoking, n (%) 4.19 
9 rs7894089, n (%) 4.13 
10 Smoking risk factor identified by 
Physician, n (%) 
3.97 
11 Amount of smoking, n (%) 3.32 
12 rs465189, n (%) 2.52 
13 rs7389298, n (%) 2.25 
14 rs17394079, n (%) 2.01 
15 Sphincter of Oddi disorders risk 
factor identified by Physician, n 
(%) 
1.86 
16 rs2129557, n (%) 1.76 
17 Family history of AP, n (%) 1.72 
18 rs10017798, n (%) 1.66 
19 rs2050500, n (%) 1.25 
20 rs2302604, n (%) 1.23 
21 rs10009455, n (%) 1.11 
22 rs12582707, n (%) 0.9 
23 rs9295689, n (%) 0.33 
24 rs528431, n (%) 0.08 
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rs10818187, n (%)    
Without rare allele 39 (79.59) 10 (20.41) 0.0033 
With rare allele 73 (55.73) 58 (44.27)  
rs10108543, n (%)    
Without rare allele 52 (72.22)  20 (27.78) 0.0199 
With rare allele 60 (55.05) 49 (44.95)  
rs7438388, n (%)    
Without rare allele 70 (68.63) 32 (31.37) 0.0336 
With rare allele 42 (53.16) 37 (46.84)  
rs7338234, n (%)    
Without rare allele 86 (56.95) 65 (43.05) 0.0022 
With rare allele 26 (86.67) 4 (13.33)  
rs7894089, n (%)    
Without rare allele 76 (56.30) 59 (43.70) 0.0081 
With rare allele 36 (78.26) 10 (21.74)  
rs465189, n (%)    
Without rare allele 86 (67.19) 42 (32.81) 0.0223 
With rare allele 26 (49.06) 27 (50.94)  
rs7389298, n (%)    
Without rare allele 70 (67.96) 33 (32.04) 0.0395 
With rare allele 39 (52.70) 35 (47.30)  
rs17394079, n (%)    
Without rare allele 71 (59.17) 49 (40.83) 0.2921 
With rare allele 41 (67.21) 20 (32.79)  
rs2129557, n (%)    
Without rare allele 104 (63.80) 59 (36.20) 0.1085 
With rare allele 8 (44.44) 10 (55.56)  
rs10017798, n (%)    
Without rare allele 78 (60.00) 52 (40.00) 0.4061 
With rare allele 34 (66.67) 17 (33.33)  
rs2050500, n (%)    
Without rare allele 77 (58.78) 54 (41.22) 0.1646 
With rare allele 35 (70.00) 15 (30.00)  
rs2302604, n (%)    
Without rare allele 70 (58.82) 49 (41.18) 0.2732 
With rare allele 41 (67.21) 20 (32.79)  
rs10009455, n (%)    
Without rare allele 97 (59.88) 65 (40.21) 0.1054 
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With rare allele 15 (78.95) 4 (21.05)  
rs12582707, n (%)    
Without rare allele 93 (60.30) 61 (39.61) 0.3247 
With rare allele 19 (70.37) 8 (29.63)  
rs9295689, n (%)    
Without rare allele 33 (73.33) 12 (26.67) 0.0680 
With rare allele 79 (58.09) 57 (41.91)  
rs528431, n (%)    
Without rare allele 35 (55.56) 28 (44.44) 0.0996 
With rare allele 67 (68.37) 31 (31.63)  
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 Table 6. Variable importance score in the 17th RF 
Rank in the 
17th RF 
Variable VI 
1 Age at CP diagnosis 41.64 
2 rs10818187 36.58 
3 rs7894089 21.77 
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 Table 7.  Parameter estimates in logistic regression model for age at CP diagnosis, rs10818187, rs7894089 and 
interaction effects with the risk of having constant pain 
Parameters in logistic regression β p-value 
Intercept -0.3822 0.7515 
Age at CP diagnosis -0.0142 0.5607 
RS10818187 2.5436 0.0785 
RS7894089 -2.6042 0.3456 
Age at CP diagnosis*RS10818187 -0.0335 0.2532 
Age at CP diagnosis*RS7894089 0.0405 0.4316 
RS10818187*RS7894089 -0.8860 0.7839 





 Table 8. Odd ratio in Logistic regression model for 10 years increase in age at CP diagnosis, rs10818187, 
rs7894089 with the risk of having constant pain 
Parameters in logistic regression OR 95% CI  p-value 
10 years increase Age at CP diagnosis  0.776 0.631 0.961 0.0192 
RS10818187 2.603 1.139 5.951 0.0233 
RS7894089 0.394 0.174 0.896 0.0262 
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4.0  APPLICATION OF RANDOM FORESTS TO IDENTIFY RISK FACTORS 
ASSOCIATED WITH PROGRESSION FROM RECURRENT ACUTE PANCREATITIS 
TO CHRONIC PANCREATITIS 
4.1 ABSTRACT 
It remains to be understood why some patients with recurrent acute pancreatitis (RAP) develop 
chronic pancreatitis with progressive morphological changes of the pancreas, exocrine and 
endocrine dysfunction in a short time, whereas others have recurrent attacks of AP without 
development of structural changes or dysfunction of the pancreas over a long period of time. The 
underlying risk factors contributing to the progression from RAP to CP are still rarely described. 
It has been hypothesized that the mechanisms of progression from RAP to CP should include 
genetic, environmental, and other risk factors. A computational method - Random Forests (RF) 
analyses were used to identify important risk factors contributing to the progression from RAP to 
CP in patients from North American Pancreatic Study 2 (NAPS2).  The results showed that 
smoking is the strongest risk factor associated with progression. CFTR gene is a potential risk 
factor for the progression in patients. The identification of these factors may be useful in clinical 
practice to predict early stage pancreatitis patients at risk for developing CP. 
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4.2 INTRODUCTION 
Recurrent acute pancreatitis (RAP) and chronic Pancreatitis (CP) pancreatitis are two form of 
pancreatic diseases. RAP is defined as the presence of at least two episodes of acute pancreatitis 
(AP) in a patient without morphological damage of the pancreas. CP is characterized by 
persistent inflammation and irreversible morphological changes of the pancreas that often 
accompanied by variable pain, calcifications, necrosis, fatty replacement, fibrosis, scarring, 
exocrine and/or endocrine dysfunction, and other complications.[96] 
Although AP, RAP, CP are defined as three different diseases, they are related because 
CP is often considered as the next step after RAP and RAP sometimes is a prerequisite for the 
development of CP which means RAP may be in the pathway from AP, RAP to CP.[97, 98]  
In a study by Yadav et al, they found that the median time to the second attack for AP 
was 7.2 months after the first attack of AP and the proportion of patients with RAP who received 
a diagnosis of CP was 32.3% in their population after a median of 40 months following the first 
attack of AP. [3] Nojgaard et al in a study showed that CP developed within a mean interval of 
3.5 years from the first attack of AP and the mortality rate for patients with CP with progression 
from AP was 2.7 times higher than in AP patients without chronic progression.[7] 
It remains to be established why some patients with RAP have morphological changes of 
the pancreas, exocrine and endocrine dysfunction in a short time, e.g. during a period of 40 
months after the first episode of AP, whereas others have recurrent attacks of AP without 
development of structural changes or dysfunction of the pancreas over a long period of time. The 
underlying risk factors contributing to the progression from RAP to CP are still rarely described. 
It has been hypothesized that the mechanisms of progression from RAP to CP should include 
genetic, environmental, and other risk factors.[2, 28] 
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Ammann et al conducted a sequential histological study of the pancreas in patients with 
alcoholic pancreatitis and concluded that there was pathway from AP to CP according to a 
suggested ‘necrosis-fibrosis sequence’ theory.[98, 99] The progression of alcoholic AP to 
advanced CP is determined primarily by two factors: the incidence and severity (mild or severe) 
of acute attacks of pancreatitis and the location of necrosis within the head of the pancreas.[98] 
However, This study was in alcoholic pancreatitis only without any evidence for other types of 
pancreatitis. In 1996, Whitcomb et al. identified gain-of-function mutations in the gene that 
encodes cationic trypsinogen (PRSS1) cause hereditary pancreatitis, a syndrome characterized by 
RAP and later CP.[42] They also showed that the majority of patients with hereditary 
pancreatitis recovered from AP through the normal healing process, whereas the rest of patients 
failed to recover and progressed to CP.[2, 39] Hereditary pancreatitis then has been emerged as 
an important pancreatic disease, which was a relatively rare but a breakthrough in understanding 
of RAP and CP.[39]  
Currently, the knowledge of the relationship among AP, RAP and CP is not completely 
understood and previous findings stimulates researchers to pay more interested in identifying 
which patients with AP and RAP develop CP, understanding the underlying mechanisms 
involved so that the disease progression to CP could be prevented or early detected.  
Whitcomb et al. defined a “sentinel acute pancreatitis event” (SAPE) hypothesis model 
that organizing factors associated with AP according to a hypothetical pathway that leads from 
the first attack of AP towards CP.[2, 30, 41] The first event of AP comes from factors that cause 
pancreatic injury and then trigger a series of events that potentially lead to CP. They proposed 
that a SAPE must occur for the development of CP. The events from the second attack may 
involve a variety of risk factors such as alcohol, smoking, and genetic mutations or other 
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undiscovered factors affect the pancreas to cause various inflammation and inflammation-
associated complications.[30] Therefore, current research efforts are focusing on identifying risk 
factors, mechanisms, and biomarkers of such a pathways progression to CP. The goal of this 
study was to identify important risk factors contributing to the progression from RAP to CP. 
4.3 MATERIALS AND METOHDS 
Study Population 
Study subjects and data were derived from the North American Pancreatic Study 2 
(NAPS2). The NAPS2 Program was designed to help researchers to understand the mechanisms 
leading to RAP, CP and their complications in human subjects. The overall objective was to 
ascertain several thousand patients with RAP, CP and controls with detailed risk assessment and 
deep phenotyping linked to biomarker and genetic information for cross sectional and 
observational follow-up studies. Enrollment was complete in September 2006 and there were a 
total of 1000 patients (540 subjects with CP, 460 with RAP) and 695 controls who completed 
consent forms and questionnaires and donated blood samples comprised the final dataset.[24] 
In NAPS2, CP was confirmed by imaging studies and RAP was defined by the presence 
of two or more attacks of documented AP but with no imaging evidence of CP. The age of the 
diagnosis of first attack of AP and the age of diagnosis of CP were collected. The number of 
additional attacks of AP was also collected in RAP and CP patients.  
In the current study, we defined two groups of patients. The RAP patient group was 
defined as participants who had documented the first AP attack more than 4 years before their 
age at enrollment of NAPS2 and had one or more additional episodes of AP attacks but had 
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never been diagnosed as CP. The CP patient group was defined as participants who had been 
diagnosed as CP at enrollment of NAPS2 and had documented first AP attack with additional 
episodes of AP attacks within 4 years before their age at diagnosis of CP. 
Demographic and Clinical Variables 
A total of 36 demographic and clinical variables were extracted or computed from two 
comprehensive patient and physician questionnaires in NAPS2 study for the use for current 
study. Patient’s gender, race, Ashkenazi Jewish heritage, family history of any pancreatic 
disease, age of the first AP diagnosis, the severity of the documented first AP attacks, drinking 
history (never drink, ever drink), alcohol consumption in the months before getting pancreatitis 
(abstainer, light drinker, moderate drinker, heavy drinker or very heavy drinker), smoking (non-
smoker, former smoker, current smoker), amount of smoking (none, less than 1 pack per day, 
more than 1 pack per day), TIGAR-O etiologic risk factors including hyperlipidemia, 
hypercalcemia, chronic renal failure, medications, toxins, idiopathic factors, hereditary factors, 
Cationic Trypsinogen mutation, CFTR mutations, SPINK1 mutations, Alpha 1-antitrypsin 
deficiency, other genetic factors, isolated autoimmune pancreatitis (AIP) factor, Inflammatory 
bowel disease AIP factor, other AIP factors, postnecrotic, vascular diseases/ischemic, 
postirradiation, pancreas divisum, sphincter of oddi disorders, duct obstruction, preampullary 
duodenal wall cysts, posttraumatic pancreatic duct scar, intraductal papillary mucinous neoplasm 
(IPMN), pancreatic cancer, gallstones, other risk factors. 
Genetic Variables 
Genetic variants was extracted from patient blood samples using the Qiagen FlexiGene 
DNA Kit (Qiagen Inc, Valencia, CA, USA).[93] Genotyping was performed at the University of 
Pittsburgh Genomics and Proteomics Core Laboratories using the  MassARRAY iPLEX GOLD 
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(Sequenom, Inc, San Diego, CA, USA). A total of 71 SNPs from a group of gene loci including 
PRSS1, PRSS2, SPINK1, CFTR, CASR, CTRC, CLDN2 were genotyped because they were 
found to be associated with the risk of pancreatitis reported from a number of previous 
studies.[30] 
4.4 ANALYSIS 
In this study, all genetic variants were analyzed as binary categorical variables with common 
allele homozygotes in SNPs were treated as reference and hetetozygote and rare allele 
homozygote genotypes were assigned as risk genetic variants. Distribution of all 107 candidate 
predictor variables were reported as means and standard deviation for quantitative data and were 
compared between two study groups using Student’s t-test or Mann–Whitney U test. Qualitative 
scales were reported as counts and proportions and compared using chi-squared tests or Fisher’s 
exact tests. 
Random Forest (RF) algorithm, an ensemble of hundreds to thousands of decision tree, 
was used to help to address the study purpose by its ability of dealing with large number of 
candidate predictor variables. RF is an ensemble of large amount of individual decision trees by 
randomly selecting a bootstrap subset sample of two-thirds of whole sample per tree and 
randomly selecting a subset of all predictor variables at each node of the tree. At each node, RF 
selects the predictor variable that best splits data into two child nodes.[61] This process allows 
for all demographic, clinical and genetic factors to work simultaneously in predicting the 
progression from RAP to CP. RF determines prediction error using the out of bag sample (OOB), 
those one-thirds of subjects not randomly selected to build a given individual tree. RF works 
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through this process of selecting bootstrap samples to build the tree and using the OOB samples 
to determine error and variable importance. The variable importance was evaluated using 
permutation importance. The given variable was randomly permuted in the OOB sample for the 
tree and new estimate of OOB error was calculated. All candidate predictor variables in the 
model were ranked based on the difference between this estimate and the original OOB error. 
The larger increase in prediction error indicates a stronger association between a given predictor 
variable and the progression from RAP to CP because random permutation destroys their 
original relationship in OOB sample and lead to worse prediction error.  
To identify important risk factors associated with the disease progression from RAP to 
CP, we used an iterative RF analysis framework to identify important risk factors for further 
examination regarding to the predictive ability for the disease progression outcome in those 
patients with RAP. To build the 1st RF, all candidate demographic, clinical, and genetic variable 
were inputted simultaneously in the 1st RF analysis without any variable pre-selection. The RF 
analysis then generated a ranking of variable importance for all predictors according to the 
importance score. After evaluation of all variables in the ranking, 20% of variables with the 
lowest importance score was dropped. A second RF was built using the rest of 80% variables 
follow the same algorithm to create new variable importance score and ranking.[87] This 
iteration process was repeated to build up a series of RF models and the last RF analysis was 
implemented using two variables left. After building all RF, The OOB error from all RF were 
evaluated. In steading of selecting the best model, our purpose is to use RF analysis to help us to 
select a relatively less complex and parsimonious model with minimum number of predictor 
variables which performs not significantly worse than the best model regarding to the 
classification accuracy (OOB error). Therefore, if there is a RF with smaller number of variables 
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and the OOB error is not significant higher than the RF with the lowest OOB error, the variables 
in this RF model were analyzed using logistic regression for further evaluation. The area under 
the receiver operation characteristic (ROC) curves (AUC) from logistic regression model were 
also generated to examine model prediction abilities. If AUC exceeds the critical value of 0.7, 
the model is considered with high predictive power. To compare the variables obtained from RF 
analysis to the variables obtained from the traditional approach of multivariable modeling, a 
logistic regression based on stepwise variable selection procedure for all 107 candidate variable 
was performed. 
RF analyses were carried out using Salford Predictive Modeler, version 7.0 (Salford 
Systems, San Diego, CA) with the recommended parameter settings: the number of trees was set 
to ntree=1000; the number of variables to test at each node was set to mtry=√N (N=Total number 
of variables used in each RF). The OOB error were generated for each RF analysis and the 
variable importance score was computed by permutation importance method. 
Multivariable logistic regression model was built using the most promising variables 
found in RF analysis and odds ratio (OR) with 95% confidence interval (CI) were calculated. All 
descriptive and logistic fregression analyses were carried out using SAS, version 9.3 (SAS, Inc., 
Cary, NC). 
4.5 RESULTS 
In NAPS2 study, there were 460 RAP and 540 CP patients enrolled.[24] Among them, 95 RAP 
patients and 92 CP patients were eligible for analysis for the current study regarding to criteria 
described above. Due to availability of genetic variants data, there were 80 patients enrolled into 
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RAP group and 65 patients enrolled into CP group for analysis. Total population in the current 
study is N=145. 
The distribution of all demographic and clinical candidate variables were presented in 
Table 9. A total of 107 candidate variables were selected to train the 1st RF model including 36 
demographic or clinical predictor variables, and 71 pancreatitis-related genetic variants. The 
OOB error rate of the 1st RF was 28.97% which means it had an overall accuracy of 71.0% in 
predicting the patient disease progression from RAP to CP. Among all 107 variables, 53 of them 
had zero of negative variable importance score and 54 of them had variable importance score 
greater than zero. The ranking of all 107 variables importance was generated based on their 
importance score. After the 1st iteration of RF, the 2nd RF model was built by dropping 20% 
(n=21) of all variables with lowest importance score in the 1st RF. The 2nd RF model included 
86 candidate variables and a new variable importance score was computed. The OOB error rate 
of the 2nd RF also equaled to 28.97%. Using the same iteration procedure, a total of 18 RF 
models were analyzed and the last model was built by 2 variables only. All OOB error rates and 
number of variable used in each RF analysis are listed in Table 10 and the OOB error rate curve 
from the 1st RF to the 18th RF is graphed in Figure 6.  
From the summary of all RF analysis, both the 8th RF model with 22 variables and the 
9th RF model with 18 variables has the lowest OOB error rate (22.76%). The rankings of 
variable importance score for these two models are listed in Table 11. Smoking status which 
categorized as non-smoker, past smoker, and current smoker, was the most important risk factor 
influencing the progression consequence from RAP to CP. The variable importance scores for 
smoking status were dramatically higher in both models (48.02, 42.79) compared to the second 
important risk factor the patient drinking category before getting pancreatitis (12.8, 14.67). Other 
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top important risk factors with variable importance score greater than 3 calculated by 
permutation imputation in both RF models included amount of smoking, patient age at the 1st 
AP attack, and two genetic variants rs213938 and rs213945. The results indicated that smoking 
status was the most important predictor varaibles 
The OOB error rate from 9th to 16th RF analyses were fluctuated between 22.76% and 
28.28% and then the OOB error rate of  the 17th RF built by 3 variables significantly increased 
to 33.13% and continuously increased to 33.79% in the 18th model, the last RF model built by 2 
variables, smoking status and drinking category. The results indicated that the 4th important 
predictor variable, which was ranked in the last in the 16th RF model should be included. The 
variable importance score and distribution in the 16th RF analysis are listed in Table 12. From 
the 16th RF model, smoking status, drinking category before getting pancreatitis, amount of 
smoking, and genetic variants rs213938 were considered to be a set of important risk factors 
associated with the development from RAP to CP.  
A multivariable logistic regression model was analyzed using 4 important predictor 
variables, smoking status, drinking category before getting pancreatitis, amount of smoking, and 
rs213938. The result showed that only amount of smoking was not significant in the 
multivariable regression model. (p=0.38) The correlation between smoking status and amount of 
smoking was evaluated and they were highly correlated (r=0.83, p<0.001). This result indicates 
that the ability of RF to identify relevant predictor variables when they have similar impact on 
outcome of interest and are highly correlated, e.g. genetic variants in same gene loci. From Table 
11, the importance scores for SNPs rs213938 and rs213945 could also reflect this scenario in 
which rs213945 always followed rs213938 in the rankings with similar importance score because 
they are highly correlated (r=0.98, p<0.001) and in the same gene CFTR. 
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To identify a small set of predictor variables that could be used for clinical purpose and 
avoid violation of multicollinearity assumption in statistical regression model, a new 
multivariable logistic regression model was built using the other three important predictor 
variables, smoking status, drinking category before getting pancreatitis, and rs213938. The full 
model with interactions was not fit since there was no interaction existing amongst three 
variables. The final model with three main effects showed that current smokers (OR=20.78 CI: 
6.30-68.53) and genetic variants rs213938 (OR=2.98 CI: 1.22-7.31) were significantly associated 
with a higher risk for development of CP from RAP. Patients with alcohol consumption history 
showed a tendency towards a lower risk as to the progression, which was significantly in light 
and heavy drinkers (Table 13). The AUC of the logistic regression is 0.85 indicate a high 
prediction accuracy. 
In the logistic regression model with a stepwise variable selection procedure (P < 0.30 for 
entry in the model and P > 0.35 for removing the variables), there were 29 of all 145 subjects 
deleted in the modeling because of the missing values. The variables selected by the stepwise 
logistic regression were listed in Table 14. 
4.6 DISCUSSION 
This study examined a large number of demographic, clinical and genetic variables using a novel 
computational method of RF followed by traditional statistical regression models to identify 
combinations among these predictors in the relationship with the disease progression from RAP 
to CP. Using a sequence of RF models, we successfully identified a group of important risk 
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factors with the most contribution to the disease outcome and examined further by multivariable 
logistic regression. 
The results from this study demonstrated that smoking is the most important risk factor to 
the development of CP in RAP patients. The variable importance score of smoking status from 
RF analysis was significantly higher than any other variables. In multivariable logistic regression 
model, smoking status was also significantly associated with disease progression and current 
smokers was identified as the most contributor in the progression from RAP to CP (adjusted 
OR=20.78). However, there was no increased risk in past smokers compared to non-smokers. 
This result confirmed previous findings that smoking is an important risk factors for CP.[100] 
The alcohol consumption is also significantly related to the progression from RAP to CP. 
Alcohol drinking has been widely recognized as a major risk factor for pancreatic diseases. 
However, a recent study reported that alcohol intake is not significantly associated with the 
progression from RAP to CP.[7] In our study, compared to abstainers, light, moderate and heavy 
drinkers tend to slightly decrease the risk of developing CP from RAP after adjusting for other 
variables. The higher risk in abstainers might be due to other etiologic causes and the small 
sample size in each category. Therefore, the effect of alcohol consumption in the disease 
progression should be further investigated. 
The SNP rs213938, which is in CFTR (cystic fibrosis transmembrane conductance 
regulator) gene was significantly associated with higher risk of developing CP in RAP patients. 
From the results of RF analyses, a group of SNPs in CFTR gene were also identified that ranked 
at the top of variable importance score. In the 9th RF model which had the best prediction 
accuracy, 6 of 10 all candidate SNPs are located in CFTR gene (rs213938, rs213945, 
rs10487368, rs2237723, rs17449197, rs17451754). The CFTR gene mutations have been 
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suggested as a pancreatitis related genes that cause cystic fibrosis, an autosomal recessive disease 
characterized by the development of CP because CFTR gene were found to linked with an extra–
acinar cell mechanism to eliminate trypsin by flushing it out of the pancreatic duct and into the 
duodenum. Therefore, mutations in CFTR gene reduce fluid secretion and trypsinogen/trypsin 
wash-out.[28, 30]  
In stepwise logistic regression model, there were 29 incomplete subjects were listwise 
deleted due to missing values resulted in smaller of sample size and potential of loss of power to 
detect associations. However, in RF analysis, the missing values were automatically imputed 
using the most frequent –non-missing value or median. Missing value is frequently happened in 
high-dimensional data. The current study demonstrated the advantage of RF to handle missing 
value and therefore successfully identify important predictor variables for modeling purpose. 
The key findings from this study indicate that smoking, alcohol drinking, and genetic 
variants in CFTR are important determinants for the development of CP in patients with RAP in 
the short period of time. Analysis of the NAPS2 data indicates that using patients smoking status, 
drinking category, and SNP rs213938 could be potentially used to make a disease progression 
prediction in RAP patients. 
4.7 LIMITATIONS 
There are some limitations in current study. First, the data for analysis was from a cross-sectional 
study thus the patients answering about past AP events may be not accurate. Second, the results 
from RF analyses did not provide visual information about interaction effects among predictor 
variables. The variables in the ranking of variable importance may have interaction effects with 
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others but they were not specified. Third, the variable importance ranking in RF does not have a 
threshold to show evaluate the significance of importance which made them hard to interpret 
from a statistical perspective and make the decision on variable selection difficultly. Finally, the 
sample size was relatively small and therefore the association between all candidate predictor 
variables and disease progression from RAP to CP may not be truly reflected. 
4.8 CONCLUSIONS 
We combined RF analyses and logistic regression models to analyze NAPS2 data, and was able 
to identify important risk factors associated with disease progression from RAP to CP within a 
time frame of 4 years. Smoking is the strongest risk factor associated with progression. CFTR 
gene is a potential risk factor for the progression in patients. The identification of these factors 
may be useful in clinical practice to predict early stage pancreatitis patients at risk for developing 
CP. Certainly, additional research is needed to evaluate the findings from this study. 
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4.9 TABLES AND FIGURES 






Gender, n (%)    
Male 35 (50.00)  35 (50.00) 0.2263 
Female 45 (60.00) 30 (40.00)  
Race, n (%)    
White 80 (55.17) 65 (44.83) . 
Other 0 (0) 0 (0)  
Jewish heritage, n (%)    
No 71 (52.99) 63 (47.01) 0.3218 
One parent 2 (100) 0 (0)  
Both Parents 5 (83.33) 1 (16.67)  
Unknown 1 (50.00) 1 (50.00)  
Drinking category in period before pancreatitis, n (%)    
Abstainer 14 (43.75) 18 (56.52) 0.0033 
Light 37 (72.55) 14 (27.45)   
Moderate 12 (50.00) 12 (50.00)   
Heavy 10 (62.50) 6 (37.50)   
Very heavy 5 (25.00) 15 (75.00)   
Ever Drink, n (%)    
No 14 (43.75) 18 (56.52) 0.1521 
Yes 65 (58.04) 47 (41.96)  
Smoking, n (%)    
Never 41 (75.93) 13 (24.07) <0.0001 
Past 30 (65.22) 16 (34.78)  
Current 8 (18.18) 36 (81.82)  
Amount of smoking, n (%)    
Never 41 (75.93) 13 (24.07) 0.0011 
<1 pack/day 18 (51.43) 17 (48.57)   
≥1 pack/day 29 (40.82) 29 (59.18)   
Family history of pancreatitis, n (%)    
No 62 (56.53) 48 (43.64) 0.7905 
Yes 15 (53.57) 13 (46.43)  
Age at AP diagnosis, mean (SD) 41.45 (16.59) 47.50 (15.63) 0.0266 
AP severity, n (%)    
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Mild 37 (48.05) 40 (51.95) 0.1861 
Moderate 8 (47.06) 9 (52.94) 
Severe 29 (64.44) 16 (35.56) 
Etiologies 
Hyperlipidemia, n (%) 
No 64 (52.46) 58 (47.54) 0.1302 
Yes 16 (69.57) 7 (30.43) 
Hypercalcemia, n (%) 
No 79 (56.03) 62 (43.97) 0.1978 
Yes 1 (25.00) 3 (75.00) 
Medications, n (%) 
No 72 (53.73) 62 (46.27) 0.2233 
Yes 8 (72.73) 3 (27.27) 
Chronic Renal Failure, n (%) 
No 79 (54.86) 65 (45.14) 0.5517 
Yes 1 (100) 0 (0) 
Toxins, n (%) 
No 80 (55.17) 65 (44.83) . 
Yes 0 (0) 0 (0) 
Idiopathic factors, n (%) 
No 38 (52.05) 35 (47.95) 0.4472 
Yes 42 (58.33) 30 (41.67) 
Genetic factors, n (%) 
No 74 (54.01) 63 (45.99) 0.1570 
Yes 6 (75.00) 2 (25.00) 
CFTR mutation, n (%) 
No 73 (53.28) 64 (46.72) 0.0586 
Yes 7 (87.50) 1 (12.50) 
SPINK1 mutation, n (%) 
No 79 (54.86) 65 (45.14) 0.5517 
Yes 1 (100) 0 (0) 
Alpha 1-antitrypsin deficiency, n (%) 
No 80 (55.17) 65 (44.83) . 
Yes 0 (0) 0 (0) 
Other genetic factors, n (%) 
No 78 (54.93) 64 (45.07) 0.4127 
Yes 2 (66.67) 1 (33.33) 
IBD Autoimmune, n (%) 
No 78 (54.93) 64 (45.07) 0.4127 
Yes 2 (66.67) 1 (33.33) 
Isolated Autoimmune, n (%) 
No 80 (55.56) 64 (44.44) 0.4483 
Yes 0 (0) 1 (100) 
Table 9 Continued 
86 
Other AIP, n (%)    
No 80 (55.17) 65 (44.83) . 
Yes 0 (0) 0 (0)  
Postnecrotic, n (%)    
No 79 (56.43) 61 (43.57) 0.1087 
Yes 1 (20.00) 4 (80.00)  
Postirradiation, n (%)    
No 80 (55.56) 64 (44.44) 0.4483 
Yes 0 (0) 1 (100)  
Vascular Diseases / ischemic, n (%)    
No 80 (55.17) 65 (44.83) . 
Yes 0 (0) 0 (0)  
Pancreas Divisum, n (%)    
No 74 (57.81) 54 (42.19) 0.0794 
Yes 6 (35.29) 11 (64.71)  
Sphincter of Oddi disorders, n (%)    
No 64 (52.89) 57 (47.11) 0.2152 
Yes 16 (66.67) 8 (33.33)  
Posttraumatic pancreatic stricture, n (%)    
No 80 (55.17) 65 (44.83) . 
Yes 0 (0) 0 (0)  
Preampullary duodenal diverticulum, n (%)    
No 80 (55.17) 65 (44.83) . 
Yes 0 (0) 0 (0)  
Duct obstruction, n (%)    
No 75 (55.56) 60 (44.44) 0.2409 
Yes 5 (50.00) 5 (50.00)  
Pancreatic cancer, n (%)    
No 79 (54.86) 65 (45.14) 0.5517 
Yes 1 (100) 0 (0)  
IPMN, n (%)    
No 78 (54.44) 65 (45.45) 0.3027 
Yes 2 (100) 0 (0)  
Gallstones, n (%)    
No 75 (56.82) 57 (43.18) 0.2042 
Yes 5 (38.46) 8 (61.54)  
Miscellaneous factors, n (%)    
No 71 (52.21) 65 (47.79) 0.0038 
Yes 9 (100) 0 (0)  
 
Table 9 Continued 
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 Table 10. Number of variables and OOB error rate of each RF analysis 
RF analysis Number of variables OOB error (%) 
1 107  28.97 
2 86   28.97 
3 69 28.28 
4 55 28.28 
5 44 26.21 
6 35 24.14 
7 28 25.52 
8 22 22.76 
9 18 22.76 
10 14 24.14 
11 11 26.90 
12 9 28.28 
13 7 26.21 
14 6  24.14 
15 5  26.21 
16 4  24.14 
17 3  33.10 
18 2  33.80 
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 Figure 6. OOB error rate curve for all RF analyses 
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 Table 11. Variable importance score in the 8th and 9th RF model 
 8th RF  9th RF  
Rank Variables VI score Variable VI score 
1 Smoking 48.02 Smoking 42.79 
2 Drinking Category 12.8 Drinking Category 14.67 
3 Amount of Smoking 8.64 Amount of Smoking 8.99 
4 rs213938 4.45 Age at 1st AP diagnosis 4.18 
5 rs213945 3.46 rs213938 3.91 
6 Age at 1st AP diagnosis 3.02 rs213945 3.84 
7 Pancreas Divisum Risk Factor 2.42 Pancreas Divisum Risk Factor 2.69 
8 Hyperlipidemia Risk Factor 2.03 Hyperlipidemia Risk Factor 2.61 
9 Drinking History 1.72 rs17250717 2.07 
10 rs17250717 1.66 rs10273639 2.02 
11 rs10273639 1.59 Other Risk Factor 1.97 
12 Other Risk Factor 1.53 rs10487368 1.93 
13 rs2237723 1.4 Drinking History 1.89 
14 rs1393198 1.38 rs10934578 1.87 
15 rs10934578 1.26 rs1393198 1.47 
16 rs17451754 1.1 rs2237723 1.27 
17 rs10487368 0.93 rs17449197 0.98 
18 rs17449197 0.76 rs17451754 0.86 
19 rs12008279 0.74   
20 Ashkenazi Jewish heritage 0.63   
21 rs2202127 0.24   
22 Medications Risk Factor 0.23   
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 Table 12. Importance score and distribution of predictor variables in the 16th RF 









1 Smoking, n (%) 61.48     
 Never  54 41 (75.93) 13 (24.07) <0.001 
 Past  46 30 (65.22) 16 (34.78)  
 Current  44 8 (18.18) 36 (81.82)   
2 Drinking category in period 
before pancreatitis, n (%) 
14.22     
 Abstainer  32 14 (43.75) 18 (56.52) 0.003 
 Light  51 37 (72.55) 14 (27.45)   
 Moderate  24 12 (50.00) 12 (50.00)   
 Heavy  16 10 (62.50) 6 (37.50)   
 Very heavy  20 5 (25.00) 15 (75.00)   
3 Amount of smoking, n (%) 13.91     
 Never  54 41 (75.93) 13 (24.07) 0.001 
 <1 pack/day  35 18 (51.43) 17 (48.57)   
 ≥1 pack/day  49 29 (40.82) 29 (59.18)   
4 rs213938, n (%) 10.39     
 Without rare allele  99 61 (61.62) 38 (38.38) 0.022 
 With rare allele  46 19 (41.30) 27 (58.70)  
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 Table 13. Smoking, Drinking Category, rs213938 and the risk of progression from RAP to CP 
Parameters in logistic regression OR 95% CI  p-value 
Smoking (vs Never)    <0.001 
Past 2.66 0.93 7.61  
Current 20.78 6.30 68.53  
Drinking Category (vs Abstained)    0.009 
Light 0.16 0.05 0.50  
Moderate 0.27 0.07 1.08  
Heavy 0.14 0.03 0.72  
Very heavy 0.80 0.17 3.70  
rs213938 2.98 1.22 7.31 0.017 
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 Table 14. Parameter estimates in logistic regression model using stepwise variable selection 
Parameters  β p-value 
Intercept -0.5735 0.2565 
Past smoker 1.2203 0.0772 
Current smoker 4.2855 <.0001 
Medication risk factors -3.6258 0.0017 
Ever drinker -2.1132 0.0026 
Postnecrotic risk factors  2.9783 0.0207 
Hypercalcemia risk factors 4.5751 0.0354 
rs13221882 1.9544 0.0134 
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5.0  DISCUSSION 
5.1 SUMMARY OF FINDINGS 
This dissertation introduced the principles of random forests (RF), reviewed the RF 
methodology, described its advantages and limitations, and provided epidemiological examples 
to explore the use of RF to analyze high dimensional data in epidemiology. By analyzing large 
scale epidemiological data combining demographical, clinical and genetic variables from 
NAPS2-CV and NAPS2 study, the dissertation developed a framework of combining RF 
analyses with traditional statistical analyses to investigate important risk factors associated with 
different pain patterns in patients with CP and disease progression from RAP to CP. The 
dissertation provided a novel data analytic strategy to support big data analysis in 
epidemiological researches. 
The first paper of this dissertation was a review paper focused on RF methodology. RF 
has been becoming a popular non-parametric algorithm in computational method and used in 
many scientific areas in the context of big data era. RF is an ensemble of  CART-like individual 
decision trees introduced by Leo Breiman in 2001. RF could handle both classification and 
regression problems to explore data structure and hidden information in high dimensional data.  
RF modeling is featured by a two-way randomness through random sub-sampling and 
random variable selection in tree-building process and has been tested with higher prediction 
 94 
accuracy compared to individual decision tree method such as CART. RF deals with correlated 
predictor variables and integrates complex interaction effects during modeling process. The most 
attracting feature from RF is that it could evaluate the entire effects of all predictor variables on 
outcome variable and produce a ranking of variable importance scores regarding to their 
discrimination ability on the outcome. RF has been applied in a variety of epidemiological 
studies especially in genetic epidemiology to help identify unknown relationship in high 
dimensional data.  
The second paper focused on identifying important risk factors that associated with 
different temporal pain patterns in CP patients. The study population were from NAPS2-CV 
study, 112 patients with intermittent pain and 69 patients with constant pain. The total number of 
candidate predictor variables were 117 including demographical, clinical, genetic markers. A 
framework of RF iterations combined with logistic regression model were used to identify 
important factors associated with different temporal pain patterns in CP patients. 
A reduced RF model identified patients’ age at CP diagnosis, rs10818187, and rs7894089 
are the most three important factors to determine temporal pain patterns in CP patients. The 
multivariable logistic regression indicated that the increase of age at CP diagnosis and the SNP 
rs7894089 are significantly associated with the lower risk for constant pain whereas the SNP 
rs10818187 are significantly associated with the lower risk for constant pain. No interaction 
effects were significant among age at CP diagnosis, rs7894089, and rs10818187. The 
identification of these factors may be useful in clinical practice to identify individuals at risk for 
the constant pain at the early stage in CP. 
A larger RF model with 24 predictor variables yielded the lowest OOB error indicating 
that all 24 variables were potentially related to the determination of different temporal pain 
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patterns in CP patients. The results indicated that the underlying mechanisms contributing to pain 
patterns in CP patients were complex. 
The third paper focused on using RF iterations and logistic regression model to identify 
important risk factors contributing to disease progression from RAP to CP in a period of 4 years 
after the 1st attack of AP. This study found that smoking was the most important risk factor to 
the progression compared to any other risk factors. Gene mutations in CFTR gene also 
contributed a lot in the progression. The identification of these factors may be useful in clinical 
practice to predict early stage pancreatitis patients at risk for developing CP. The result from RF 
analysis also showed that a group of 18 to 22 risk factors were related to the progression from 
RAP to CP indicating that the causes of disease progression were complex and need further 
investigation. 
5.2 STRENGTHS 
There are several strengths in this current dissertation research. The review of RF described the 
methodology of RF and its implementation in data analysis for epidemiological researches. The 
first paper was a beneficiary of expert review, which provide examples of RF applications in 
epidemiology and possible directions for future researches. 
The development of an analytic framework of RF analyses and traditional statistical 
analyses in large pancreatitis studies allowed for the examination of large amount of predictor 
variables simultaneously and their influence on different pain patterns in patients with CP and 
disease progression from RAP to CP in a multivariable way. 
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5.3 LIMITATIONS 
In application of RF analysis, the interaction effects by predictor variables were not specified 
because RF did not provide information on how they interact with each other. It made the 
difficulty in interpreting results. 
Second, RF analysis did not provide a threshold to define which predictor was significant 
and/or should be selected for further investigation. Variable importance score always provided a 
ranking which made them hard to interpret from a statistical perspective and make the decision 
on variable selection.  
Third, there was no formal way to select the optimal RF model, the smaller RF model 
was selected as the optimal model followed by statistical analysis based on its simplicity for 
clinical purpose. 
Fourth, the number of patients who chose to participate in current studies were small. 
This small sample limits the power to detect true differences between groups and it calls into 
question to representativeness of the sample. 
5.4 PUBLIC HEALTH SIGNIFICANCE 
CP is a major burden of gastrointestinal disease in the United States accounts for significant 
healthcare costs to the society. Abdominal pain is the most common symptom in CP patients and 
the relapse or persistence of pain is challenging medical practice. It has been proposed that a 
combination of genetic, environmental, and metabolic risk factors contribute to the development 
of CP and pain patterns in CP patients. This dissertation provided a data analysis framework 
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utilizing the novel computational method RF to better understand complex mechanisms in the 
development of CP and pain patterns in CP patients. RF is suitable for analyzing high 
dimensional data for epidemiological studies in the context of the big data era. 
5.5 FUTURE STUDIES 
Future research on should continue to concentrate on understanding complex effects of genetic 
variations and environmental factors in CP. The capability of RF should be further developed in 
analyzing large epidemiological studies. RF analysis are needed to fit in the statistical framework 
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